ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Ph. Gabriel Steg; Stefan K. James; Dan Atar; Luigi P. Badano; Carina Blomstrom Lundqvist; Michael A. Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H. Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J. Lenzen; Kenneth W. Mahaffey; Marco Valgimigli; Arnoud van't Hof; Petr Widimsky; Doron Zahger; Jeroen J. Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A. Popescu; Željko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; David Hasdai; Felicity Astin; Karin Åström-Olsson; Andrzej Budaj; Peter Clemmensen; Jean-Philippe Collet; Keith A. Fox; Ahmet Fuat; Olivija Gustiene; Christian W. Hamm; Petr Kala; Patrizio Lancellotti; Aldo Pietro Maggioni; Béla Merkely; Franz-Josef Neumann; Massimo F. Piepoli; Frans Van de Werf; Freek Verheugt; Lars Wallentin

doi:10.1093/eurheartj/ehs215

Loading next page...

References (380)

R. Marchioli, M. Franzosi, E. Geraci (1999)
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
The Lancet
E. Boersma, A. Maas, J. Deckers, M. Simoons (1996)
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour
The Lancet, 348
Zipes (2006)
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur Heart J, 27
J. Malone‐Lee, A. Wagg, A. Mundy, C. Fry, J. Lincoln, A. Naylor (1994)
Science of urinary incontinence Report of a Meeting of Physicians and Scientists, University College London
The Lancet, 344
F. Werf, A. Ross, P. Armstrong, C. Granger (2006)
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial
The Lancet, 367
Ole Fröbert, B. Lagerqvist, T. Gudnason, L. Thuesen, R. Svensson, G. Olivecrona, S. James (2010)
Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale.
American heart journal, 160 6
P. Sánchez, F. Gimeno, P. Ancillo, Juan Sanz, J. Alonso-Briales, F. Bosa, Ignacio Santos, J. Sanchis, A. Bethencourt, J. López-Messa, Armando Prado, J. Alonso, J. Román, F. Fernández‐Avilés (2010)
Role of the Paclitaxel-Eluting Stent and Tirofiban in Patients With ST-Elevation Myocardial Infarction Undergoing Postfibrinolysis Angioplasty: The GRACIA-3 Randomized Clinical Trial
Circulation: Cardiovascular Interventions, 3
S. Ellis, M. Tendera, M. Belder, A. Boven, P. Widimsky, L. Janssens, H. Andersen, A. Betriu, S. Savonitto, J. Adamus, J. Peruga, M. Kośmider, O. Katz, T. Neunteufl, J. Jorgova, M. Dorobanțu, L. Grinfeld, P. Armstrong, B. Brodie, H. Herrmann, G. Montalescot, F. Neumann, M. Effron, E. Barnathan, E. Topol (2008)
Facilitated PCI in patients with ST-elevation myocardial infarction.
The New England journal of medicine, 358 21
B. Scheller, B. Hennen, B. Hammer, J. Walle, C. Hofer, V. Hilpert, H. Winter, G. Nickenig, M. Böhm (2003)
Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction.
Journal of the American College of Cardiology, 42 4
Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction
Am J Cardiol, 66
G. Luca, H. Suryapranata, G. Stone, D. Antoniucci, J. Tcheng, F. Neumann, F. Werf, E. Antman, E. Topol (2005)
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
JAMA, 293 14
Abraham (2010)
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focussed update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
J Am Coll Cardiol, 56
Mehta (2001)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
Lancet, 358
M. Fokkema, P. Vlaar, T. Svilaas, M. Vogelzang, D. Amo, G. Diercks, A. Suurmeijer, F. Zijlstra (2008)
Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarction.
European heart journal, 30 8
S. Koul, J. Smith, F. Scherstén, S. James, B. Lagerqvist, D. Erlinge (2011)
Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
European heart journal, 32 23
F. Burzotta, M. Vita, Youlan Gu, T. Isshiki, T. Lefévre, A. Kaltoft, D. Dudek, G. Sardella, P. Orrego, D. Antoniucci, L. Luca, G. Biondi-Zoccai, F. Crea, F. Zijlstra (2009)
Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials.
European heart journal, 30 18
J. Schmitt, G. Duray, B. Gersh, S. Hohnloser (2009)
Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications.
European heart journal, 30 9
S. Rathore, J. Curtis, Jersey Chen, Yongfei Wang, B. Nallamothu, A. Epstein, H. Krumholz (2009)
Association of door-to-balloon time and mortality in patients admitted to hospital with ST elevation myocardial infarction: national cohort study
The BMJ, 338
S. Finfer, D. Chittock, S. Su, Deborah Blair, D. Foster, V. Dhingra, R. Bellomo, D. Cook, P. Dodek, W. Henderson, P. Hebert, S. Heritier, D. Heyland, C. McArthur, E. McDonald, I. Mitchell, J. Myburgh, R. Norton, Julie Potter, Bruce Robinson, J. Ronco (2009)
Intensive versus conventional glucose control in critically ill patients.
The New England journal of medicine, 360 13
Erik Björklund, U. Stenestrand, J. Lindbäck, L. Svensson, L. Wallentin, B. Lindahl (2006)
Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction.
European heart journal, 27 10
C. Grines, D. Marsalese, B. Brodie, J. Griffin, B. Donohue, C. Costantini, C. Balestrini, G. Stone, T. Wharton, P. Esente, M. Spain, J. Moses, M. Nobuyoshi, M. Ayres, Denise Jones, D. Mason, D. Sachs, L. Grines, W. O’Neill (1998)
Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction.
Journal of the American College of Cardiology, 31 5
Mark Kotowycz, T. Cosman, Corinne Tartaglia, Rizwan Afzal, R. Syal, M. Natarajan (2010)
Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).
American heart journal, 159 1
Si‐Hyuck Kang, J. Suh, C. Yoon, M. Cho, Young Kim, S. Chae, J. Yoon, H. Gwon, K. Han, Joo Kim, Y. Ahn, M. Jeong, Hyo‐Soo Kim, D. Choi (2012)
Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry).
The American journal of cardiology, 109 6
J. Alexander, H. Reynolds, A. Stebbins, V. Džavík, R. Harrington, F. Werf, J. Hochman (2007)
Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
JAMA, 297 15
K. Kalla, G. Christ, R. Karnik, R. Malzer, G. Norman, H. Prachar, W. Schreiber, G. Unger, H. Glogar, A. Kaff, A. Laggner, G. Maurer, J. Mlczoch, J. Slany, H. Weber, K. Huber (2006)
Implementation of Guidelines Improves the Standard of Care: The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry)
Circulation, 113
M. Brignole, A. Auricchio, G. Barón-Esquivias, P. Bordachar, G. Boriani, O. Breithardt, J. Cleland, J. Deharo, V. Delgado, P. Elliott, B. Gorenek, C. Israel, C. Leclercq, C. Linde, L. Mont, L. Padeletti, R. Sutton, P. Vardas, J. Zamorano, S. Achenbach, H. Baumgartner, Jeroen Bax, H. Bueno, V. Dean, C. Deaton, Ç. Erol, R. Fagard, R. Ferrari, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, P. Lancellotti, A. Linhart, P. Nihoyannopoulos, M. Piepoli, P. Ponikowski, P. Sirnes, J. Tamargo, M. Tendera, A. Torbicki, W. Wijns, S. Windecker, C. Blomstrom-Lundqvist, L. Badano, Farid Aliyev, D. Bänsch, Walid Bsata, P. Buser, P. Charron, J. Daubert, D. Dobreanu, S. Faerestrand, J. Heuzey, H. Mavrakis, T. McDonagh, J. Merino, M. Nawar, J. Nielsen, B. Pieske, L. Poposka, F. Ruschitzka, I. Gelder, C. Wilson (2013)
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
European heart journal, 34 29
H. Thiele, J. Wöhrle, R. Hambrecht, H. Rittger, R. Birkemeyer, B. Lauer, P. Neuhaus, O. Brosteanu, P. Sick, M. Wiemer, S. Kerber, Klaus Kleinertz, I. Eitel, S. Desch, G. Schuler (2012)
Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial
The Lancet, 379
H. Andersen, T. Nielsen, K. Rasmussen, L. Thuesen, H. Kelbaek, P. Thayssen, U. Abildgaard, F. Pedersen, J. Madsen, P. Grande, A. Villadsen, L. Krusell, T. Haghfelt, P. Lomholt, S. Husted, Else Vigholt, H. Kjaergård, L. Mortensen (2003)
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
The New England journal of medicine, 349 8
S. Goodman, R. Clare, K. Pieper, J. Nicolau, R. Storey, W. Cantor, K. Mahaffey, D. Angiolillo, S. Husted, C. Cannon, S. James, J. Kilhamn, P. Steg, R. Harrington, L. Wallentin (2012)
Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor: Insights From the Platelet Inhibition and Patient Outcomes Trial
Circulation, 125
R. Collins, R. Peto, M. Flather, S. Parish, P. Sleight, M. Conway, A. Pipilis, C. Baigent, D. Barnett, J. Boissel, A. Budaj, J. Cairns, L. Ceremużyński, Af Cohen, G. Backer, R. Díaz, F. Dienstl, P. Dove, M. Franzosi, M. Genoni, D. Halon, J. Heikkila, C. Hennekens, J. Horgan, D. Hunt, R. Kala, N. Karatzas, A. Keech, M. Keltai, J. Kjekshus, M. Kornitzer, R. Koster, P. Landless, P. Lechleitner, A. Leizorovicz, B. Lewis, L. Lundkvist, S. MacMahon, A. Maggioni, R. Malacrida, T. Meyer, T. Moccetti, D. Ocallaghan, E. Paolasso, L. Piegas, A. Reikvam, P. Ridker, T. Ryan, R. Schroder, R. Seabragomes, Jemr Sousa, G. Tognoni, A. Turpie, Valentin, J. Varigos, H. White, L. Wilhelmsen, K. Woods, S. Yusuf, A. Piombo, La Guzman, Dc Montenegro, G. Irusta, Raymond Schneider, C. Cuneo, B. Chamorro, Gerardo Espinosa, M. Moreno, Mm Rios, R. Doll, K. Fox, D. Julian, P. Meier, E. Sandoya, J. Perez (1995)
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
The Lancet, 345
V. Menon, H. White, T. LeJemtel, J. Webb, L. Sleeper, J. Hochman (2000)
The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry☆
Journal of the American College of Cardiology, 36
J. Herlitz (1994)
Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
The Lancet, 343
S. Wiviott, E. Braunwald, C. Mccabe, G. Montalescot, W. Rużyłło, S. Gottlieb, F. Neumann, D. Ardissino, Stefano Servi, S. Murphy, J. Riesmeyer, G. Weerakkody, M. Gibson, E. Antman (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
The New England journal of medicine, 357 20
B. Rauch, R. Schiele, S. Schneider, Frank Diller, N. Victor, H. Gohlke, M. Gottwik, G. Steinbeck, Ulrike Castillo, Rudolf Sack, Heinrich Worth, H. Katus, W. Spitzer, G. Sabin, J. Senges (2010)
OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction
Circulation, 122
P. Sörensson, N. Saleh, F. Bouvier, F. Böhm, M. Settergren, K. Caidahl, P. Tornvall, H. Arheden, L. Rydén, J. Pernow (2010)
Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction
Heart, 96
F. Werf (1999)
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial
The Lancet, 354
R. Lemery, Hugh Smith, E. Giuliani, B. Gersh (1992)
Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention.
The American journal of cardiology, 70 2
(1988)
Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Journal of the American College of Cardiology, 12 6 Suppl A
V. Menon, Camille Pearte, C. Buller, P. Steg, S. Forman, H. White, P. Marino, D. Katritsis, P. Caramori, R. Lasevitch, K. Loboz-grudzień, A. Zurakowski, G. Lamas, J. Hochman (2008)
Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.
European heart journal, 30 2
M. Imazio, A. Negro, R. Belli, Federico Beqaraj, D. Forno, M. Giammaria, R. Trinchero, Y. Adler, D. Spodick (2009)
Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention.
The American journal of cardiology, 103 11
M. Valgimigli, G. Campo, G. Percoco, M. Monti, F. Ferrari, C. Tumscitz, A. Zuffi, F. Colombo, M. Kubbajeh, Caterina Cavazza, E. Cangiano, M. Tebaldi, Monica Minarelli, Chiara Arcozzi, A. Scalone, A. Frangione, M. Borghesi, J. Marchesini, G. Parrinello, R. Ferrari (2010)
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplas
American heart journal, 160 5
(2010)
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options.
I. Wijnbergen, Harold Helmes, J. Tijssen, G. Brueren, K. Peels, J. Dantzig, M. Veer, J. Koolen, N. Pijls, R. Michels (2012)
Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study.
JACC. Cardiovascular interventions, 5 3
R. Mehran, Alexandra Lansky, B. Witzenbichler, G. Guagliumi, J. Peruga, B. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B. Gersh, S. Pocock, S. Wong, E. Nikolsky, L. Gambone, Lynn Vandertie, H. Parise, G. Dangas, G. Stone (2009)
Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
The Lancet, 374
G. Stone, B. Witzenbichler, G. Guagliumi, J. Peruga, B. Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, B. Gersh, S. Pocock, G. Dangas, S. Wong, Ajay Kirtane, H. Parise, R. Mehran (2008)
Bivalirudin during primary PCI in acute myocardial infarction.
The New England journal of medicine, 358 21
D. Angiolillo, M. Firstenberg, M. Price, P. Tummala, M. Hutyra, I. Welsby, Michele Voeltz, H. Chandna, Chand Ramaiah, M. Brtko, L. Cannon, C. Dyke, Tiepu Liu, G. Montalescot, S. Manoukian, J. Prats, E. Topol (2012)
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.
JAMA, 307 3
S. Silberman, Catherine Neukirch-Stoop, P. Steg (2005)
Rapid desensitization procedure for patients with aspirin hypersensitivity undergoing coronary stenting.
The American journal of cardiology, 95 4
R. Estévez-Loureiro, R. Calviño-Santos, J. Vázquez, E. Barge-Caballero, J. Salgado-Fernández, M. Piñeiro, M. Freire-Tellado, J. Varela-Portas, L. Martínez, Sandra Gómez, J. Rodríguez, N. Vázquez, A. Castro‐Beiras (2009)
Safety and feasibility of returning patients early to their originating centers after transfer for primary percutaneous coronary intervention.
Revista espanola de cardiologia, 62 12
K. Dickstein, A. Cohen-Solal, G. Filippatos, J. McMurray, P. Ponikowski, P. Poole‐Wilson, A. Strömberg, D. Veldhuisen, D. Atar, A. Hoes, A. Keren, A. Mebazaa, Markku Nieminen, S. Priori, K. Swedberg, A. Vahanian, J. Camm, R. Caterina, V. Dean, C. Funck-Brentano, I. Hellemans, S. Kristensen, K. Mcgregor, U. Sechtem, S. Silber, M. Tendera, Petr Widimsky, J. Zamorano, A. Auricchio, Jeroen Bax, M. Böhm, U. Corrà, P. Bella, P. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J. Vachiéry, F. Verheugt, F. Zannad (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡
European Journal of Heart Failure, 10
M. Simoons, E. Topol, R. Califf, F. Werf, P. Armstrong, P. Aylward, G. Barbash, E. Bates, A. Betriu, J. Chesebro, J. Col, D. Bono, J. Gore, A. Guerci, J. Hampton (1993)
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
The New England journal of medicine, 329 10
Sorajja (2005)
Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction
Eur Heart J, 26
A. Gershlick, A. Stephens-Lloyd, Sarah Hughes, K. Abrams, Suzanne Stevens, N. Uren, A. Belder, John Davis, M. Pitt, A. Banning, A. Baumbach, M. Shiu, P. Schofield, K. Dawkins, R. Henderson, K. Oldroyd, R. Wilcox (2005)
Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction.
The New England journal of medicine, 353 26
A. Natale, Jasbir Sra, K. Axtell, C. Maglio, A. Dhala, Z. Blanck, S. Deshpande, M. Jazayeri, M. Akhtar (1994)
Ventricular Fibrillation and Polymorphic Ventricular Tachycardia with Critical Coronary Artery Stenosis:
Journal of Cardiovascular Electrophysiology, 5
A. Ross, P. Molhoek, C. Lundergan, M. Knudtson, Y. Draoui, Lorna Regalado, V. Louer, F. Bigonzi, W. Schwartz, E. Jong, K. Coyne (2002)
Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin Second Trial of Heparin and Aspirin Reperfusion Therapy (HART II)
Circulation, 104
Mauri (2010)
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
Am Heart J, 160
R. Starling, Y. Naka, A. Boyle, G. Gonzalez-Stawinski, R. John, U. Jorde, S. Russell, J. Conte, K. Aaronson, E. McGee, W. Cotts, D. DeNofrio, D. Pham, D. Farrar, F. Pagani (2011)
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
Journal of the American College of Cardiology, 57 19
B. Böttiger, H. Arntz, D. Chamberlain, E. Bluhmki, A. Belmans, T. Danays, P. Carli, J. Adgey, C. Bode, V. Wenzel (2008)
Thrombolysis during resuscitation for out-of-hospital cardiac arrest.
The New England journal of medicine, 359 25
B. Pitt, F. Zannad, W. Remme, R. Cody, A. Castaigne, Alfonso Perez, J. Palensky, J. Wittes (1999)
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
The New England journal of medicine, 341 10
D. Diercks, W. Peacock, B. Hiestand, A. Chen, C. Pollack, J. Kirk, Sidney Smith, W. Gibler, E. Ohman, A. Blomkalns, L. Newby, J. Hochman, E. Peterson, M. Roe (2006)
Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative).
The American journal of cardiology, 97 4
E. Bøhmer, P. Hoffmann, M. Abdelnoor, H. Arnesen, S. Halvorsen (2010)
Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction).
Journal of the American College of Cardiology, 55 2
G. Lip (2010)
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice
Thrombosis and Haemostasis, 103
C. Patrono, F. Andreotti, H. Arnesen, L. Badimón, C. Baigent, J. Collet, R. Caterina, D. Gulba, K. Huber, S. Husted, S. Kristensen, J. Morais, F. Neumann, L. Rasmussen, A. Siegbahn, P. Steg, R. Storey, F. Werf, F. Verheugt (2011)
Antiplatelet agents for the treatment and prevention of atherothrombosis.
European heart journal, 32 23
R. Lopes, Hany Siha, Yuling Fu, R. Mehta, M. Patel, P. Armstrong, C. Granger (2011)
Diagnosing acute myocardial infarction in patients with left bundle branch block.
The American journal of cardiology, 108 6
H. Gwon, J. Hahn, Kyung-Woo Park, Y. Song, I. Chae, D. Lim, K. Han, Jin‐Ho Choi, Seung‐Hyuk Choi, Hyun-Jae Kang, B. Koo, T. Ahn, J. Yoon, M. Jeong, T. Hong, W. Chung, Y. Choi, S. Hur, H. Kwon, D. Jeon, B. Kim, S. Park, N. Lee, H. Jeon, Y. Jang, Hyo‐Soo Kim (2011)
Six-Month versus Twelve-Month Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents: 'EXCELLENT' Randomized, Multicenter Study
Circulation
P. Vardas, A. Auricchio, J. Blanc, J. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. Morgado, A. Oto, R. Sutton, M. Trusz‐Gluza (2007)
Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 9 10
Marc Cohen, G. Gensini, F. Maritz, E. Gurfinkel, K. Huber, A. Timerman, M. Krzeminska-Pakula, N. Danchin, H. White, J. Santopinto, F. Bigonzi, Carole Hecquet, L. Vittori (2003)
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial.
Journal of the American College of Cardiology, 42 8
H. White, Hirulog, Early Investigators (2001)
Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial
The Lancet, 358
R. Peters, C. Joyner, J. Bassand, Rizwan Afzal, S. Chrolavicius, S. Mehta, J. Oldgren, L. Wallentin, A. Budaj, K. Fox, S. Yusuf (2008)
The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial.
European heart journal, 29 3
G. Lip, K. Huber, F. Andreotti, H. Arnesen, J. Airaksinen, T. Cuisset, P. Kirchhof, F. Marín (2010)
Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a
European heart journal, 31 11
R. Kornowski, R. Mehran, G. Dangas, E. Nikolsky, A. Assali, B. Claessen, B. Gersh, S. Wong, B. Witzenbichler, G. Guagliumi, D. Dudek, M. Fahy, A. Lansky, G. Stone, Horizons-Ami Investigators (2011)
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
Journal of the American College of Cardiology, 58 7
K. Sjauw, A. Engström, M. Vis, R. Schaaf, J. Baan, K. Koch, R. Winter, J. Piek, J. Tijssen, J. Henriques (2008)
A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?
European heart journal, 30 4
Christian Hamm, J. Bassand, Stefan Agewall, Jeroen Bax, Eric Boersma, Héctor Bueno, Pio Caso, Dariusz Dudek, Stephan Gielen, Kurt Huber, Magnus Ohman, Mark Petrie, Frank Sonntag, M. Uva, Robert Storey, William Wijns, D. Zahger (2012)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Revista Espanola De Cardiologia, 65
R. Rossini, D. Angiolillo, G. Musumeci, P. Scuri, P. Invernizzi, T. Bass, Laurian Mihalcsik, A. Gavazzi (2008)
Aspirin desensitization in patients undergoing percutaneous coronary interventions with stent implantation.
The American journal of cardiology, 101 6
Y. Akashi, D. Goldstein, G. Bárbaro, T. Ueyama (2008)
Takotsubo Cardiomyopathy: A New Form of Acute, Reversible Heart Failure
Circulation, 118
Zhengming Chen, H. Pan, Yiping Chen, R. Peto, R. Collins, Lixin Jiang, J. Xie, Lisheng Liu, Commit (2005)
Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
The Lancet, 366
D. Backer, P. Biston, J. Devriendt, C. Madl, D. Chochrad, C. Aldecoa, A. Brasseur, P. Defrance, P. Gottignies, J. Vincent (2010)
Comparison of dopamine and norepinephrine in the treatment of shock.
The New England journal of medicine, 362 9
J. Hochman, L. Sleeper, J. Webb, T. Sanborn, H. White, J. Talley, C. Buller, A. Jacobs, J. Slater, J. Col, S. Mckinlay, T. LeJemtel (1999)
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
The New England journal of medicine, 341 9
M. Leon, D. Baim, J. Popma, P. Gordon, D. Cutlip, K. Ho, A. Giambartolomei, D. Diver, D. Lasorda, David Williams, S. Pocock, R. Kuntz (1998)
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
The New England Journal of Medicine, 339
Nathaniel Page, W. Schroeder (2007)
Rapid Desensitization Protocols for Patients with Cardiovascular Disease and Aspirin Hypersensitivity in an Era of Dual Antiplatelet Therapy
Annals of Pharmacotherapy, 41
E. Keeley, J. Boura, C. Grines (2003)
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
The Lancet, 361
G. Murray (1993)
Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators
The Lancet, 342
H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, G. Rioufol, T. Cung, E. Bonnefoy, D. Angoulvant, J. Aupetit, G. Finet, X. André‐Fouët, J. Macia, F. Raczka, Rolland Rossi, R. Itti, G. Kirkorian, G. Derumeaux, M. Ovize (2008)
Long-Term Benefit of Postconditioning
Circulation, 117
S. James, M. Roe, C. Cannon, J. Cornel, J. Horrow, S. Husted, H. Katus, J. Morais, P. Steg, R. Storey, Susanna Stevens, L. Wallentin, R. Harrington (2011)
Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
The BMJ, 342
P. Widimsky, W. Wijns, J. Fajadet, M. Belder, J. Knot, L. Aaberge, G. Andrikopoulos, J. Baz, A. Betriu, M. Claeys, N. Danchin, S. Djambazov, P. Erne, J. Hartikainen, K. Huber, P. Kala, M. Klinčeva, S. Kristensen, P. Ludman, J. Ferre, B. Merkely, D. Miličić, J. Morais, M. Noc, G. Opolski, M. Ostojić, D. Radovanović, S. Servi, U. Stenestrand, M. Studencan, M. Tubaro, Z. Vasiljevic, F. Weidinger, A. Witkowski, U. Zeymer (2009)
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries
European Heart Journal, 31
E. Veys, A. Govaerts, E. Coigne, H. Mielants, A. Verbruggen (1974)
HL-A AND INFECTIVE SACROILEITIS
The Lancet, 304
V. Roger, A. Go, D. Lloyd‐Jones, E. Benjamin, J. Berry, W. Borden, D. Bravata, S. Dai, E. Ford, C. Fox, H. Fullerton, C. Gillespie, S. Hailpern, J. Heit, V. Howard, B. Kissela, S. Kittner, D. Lackland, J. Lichtman, L. Lisabeth, D. Makuc, G. Marcus, A. Marelli, D. Matchar, C. Moy, D. Mozaffarian, M. Mussolino, G. Nichol, N. Paynter, E. Soliman, P. Sorlie, N. Sotoodehnia, T. Turan, S. Virani, N. Wong, D. Woo, M. Turner (2012)
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.
Circulation, 125 1
S. Jolly, S. Yusuf, J. Cairns, K. Niemelä, D. Xavier, P. Widimsky, A. Budaj, M. Niemelä, V. Valentín, B. Lewis, Á. Avezum, P. Steg, S. Rao, P. Gao, Rizwan Afzal, C. Joyner, S. Chrolavicius, S. Mehta (2011)
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
The Lancet, 377
S. James, D. Angiolillo, J. Cornel, D. Erlinge, S. Husted, F. Kontny, Juan Maya, J. Nicolau, J. Špinar, R. Storey, Susanna Stevens, L. Wallentin (2010)
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
European Heart Journal, 31
L. Bossaert (1998)
European Resuscitation Council guidelines for resuscitation
Cabello (2010)
Oxygen therapy for acute myocardial infarction
Cochrane Database Syst Rev, 6
(2004)
El tratamiento hipolipemiante intensivo frente al moderado con estatinas tras síndromes coronarios agudos
S. Bangalore, J. Qin, S. Sloan, S. Murphy, C. Cannon (2010)
What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?: Relationship of Blood Pressure and Cardiovascular Events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial
Circulation, 122
G. Montalescot, S. Ellis, M. Belder, L. Janssens, O. Katz, W. Pluta, P. Ecollan, M. Tendera, A. Boven, P. Widimsky, H. Andersen, A. Betriu, P. Armstrong, B. Brodie, H. Herrmann, F. Neumann, M. Effron, Jiandong Lu, E. Barnathan, E. Topol (2010)
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).
JACC. Cardiovascular interventions, 3 2
A. Berger, S. Duval, D. Jacobs, Cheryl Barber, G. Vázquez, Seungmin Lee, R. Luepker (2008)
Relation of length of hospital stay in acute myocardial infarction to postdischarge mortality.
The American journal of cardiology, 101 4
V. Džavík, V. Džavík, L. Sleeper, T. Cocke, M. Moscucci, J. Saucedo, S. Hosat, X. Jiang, J. Slater, T. LeJemtel, J. Hochman (2003)
Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry
European Heart Journal, 24
P. Widimsky, F. Roháč, J. Šťásek, P. Kala, R. Rokyta, B. Kuzmanov, M. Jakl, M. Poloczek, J. Kanovsky, I. Bernat, O. Hlinomaz, J. Bělohlávek, A. Král, V. Mrázek, V. Grigorov, S. Djambazov, R. Petr, J. Knot, D. Bílková, M. Fischerová, K. Vondrák, M. Malý, A. Lorencová (2011)
Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy?
European Heart Journal, 33
M. Tubaro, N. Danchin, P. Goldstein, Gerasinos Filippatos, Y. Hasin, M. Heras, P. Janský, T. Norekvål, E. Swahn, K. Thygesen, C. Vrints, D. Zahger, H. Arntz, A. Bellou, J. Coussaye, L. Luca, K. Huber, Y. Lambert, M. Lettino, B. Lindahl, S. McLean, L. Nibbe, W. Peacock, S. Price, T. Quinn, C. Spaulding, G. Tatu-Chiţoiu, F. Werf (2011)
Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology
Acute Cardiac Care, 13
J. Myers, M. Prakash, V. Froelicher, D. Do, S. Partington, J. Atwood (2002)
Exercise capacity and mortality among men referred for exercise testing.
The New England journal of medicine, 346 11
C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, N. Mewton, R. Elbelghiti, T. Cung, E. Bonnefoy, D. Angoulvant, C. Macía, F. Raczka, C. Sportouch, G. Gahide, G. Finet, X. André‐Fouët, D. Revel, G. Kirkorian, J. Monassier, G. Derumeaux, M. Ovize (2008)
Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
The New England journal of medicine, 359 5
Carine Milcent, B. Dormont, I. Durand-zaleski, P. Steg (2007)
Gender Differences in Hospital Mortality and Use of Percutaneous Coronary Intervention in Acute Myocardial Infarction: Microsimulation Analysis of the 1999 Nationwide French Hospitals Database
Circulation, 115
M. O’Donoghue, E. Braunwald, E. Antman, S. Murphy, E. Bates, Y. Rozenman, A. Michelson, R. Hautvast, P. Lee, S. Close, Lei-Bin Shen, J. Mega, M. Sabatine, S. Wiviott (2009)
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
The Lancet, 374
Packer (2001)
Effect of carvedilol on survival in severe chronic heart failure
N Engl J Med, 344
G. LaCanna, S. Rahimtoola, O. Visioli, R. Giubbini, O. Alfieri, M. Zognio, E. Milan, C. Ceconi, M. Gargano, R. Lorusso, R. Ferrari (2000)
Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium.
European heart journal, 21 16
R. Prondzinsky, H. Lemm, Michael Swyter, Nikolas Wegener, S. Unverzagt, J. Carter, M. Russ, A. Schlitt, U. Buerke, A. Christoph, H. Schmidt, M. Winkler, J. Thiery, K. Werdan, M. Buerke (2010)
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome*
Critical Care Medicine, 38
L. Køber, C. Torp-Pedersen, J. Carlsen, H. Bagger, P. Eliasen, K. Lyngborg, J. Videbæk, D. Cole, L. Auclert, N. Pauly, E. Aliot, S. Persson, A. Camm (1995)
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
The New England journal of medicine, 333 25
K. Fox (2003)
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
The Lancet, 362
(2001)
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction
The Lancet, 358
P. Lawler, K. Filion, M. Eisenberg (2011)
Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.
American heart journal, 162 4
D. Clement (1996)
A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
The Lancet, 348
G. Use, O. Strategies, T. Investigators (1997)
A comparison of reteplase with alteplase for acute myocardial infarction
The New England Journal of Medicine, 337
P. Henry, A. Vermillet, B. Boval, C. Guyetand, T. Petroni, J. Dillinger, G. Sideris, C. Sollier, L. Drouet (2010)
24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease
Thrombosis and Haemostasis, 105
D. Hackett, G. Davies, S. Chierchia, A. Maseri (1987)
Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy.
The New England journal of medicine, 317 17
E. Navarese, G. Luca, F. Castriota, M. Koziński, P. Gurbel, C. Gibson, F. Andreotti, A. Buffon, J. Siller-Matula, A. Sukiennik, S. Servi, J. Kubica (2011)
Low‐molecular‐weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST‐elevation myocardial infarction: a meta‐analysis
Journal of Thrombosis and Haemostasis, 9
J. Nolan, J. Soar, D. Zideman, D. Biarent, L. Bossaert, C. Deakin, R. Koster, J. Wyllie, B. Böttiger (2010)
European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary.
Resuscitation, 81 10
F. McAlister, S. Stewart, S. Ferrua, J. McMurray (2004)
Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.
Journal of the American College of Cardiology, 44 4
Cannon (2004)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
N Engl J Med, 350
G. Stone, A. Maehara, B. Witzenbichler, J. Godlewski, H. Parise, J. Dambrink, A. Ochała, Trevor Carlton, Ecaterina Cristea, S. Wolff, S. Brener, S. Chowdhary, M. El-Omar, T. Neunteufl, D. Metzger, T. Karwoski, J. Dizon, R. Mehran, C. Gibson (2012)
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.
JAMA, 307 17
Dickstein (2010)
2010 Focussed Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association
Eur Heart J, 31
K. Marill, I. deSouza, D. Nishijima, E. Senecal, G. Setnik, T. Stair, J. Ruskin, P. Ellinor (2010)
Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 17 3
C. Baigent, L. Blackwell, R. Collins, J. Emberson, Jon Godwin, R. Peto, Julie Buring, Charles Hennekens, Patricia Kearney, Tom Meade, C. Patrono, M. Roncaglioni, Alberto Zanchetti (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
Lancet, 373
A comparison of reteplase with alteplase for acute myocardial infarction (1997)
The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
N Engl J Med, 337
Mats Gulliksson, G. Burell, B. Vessby, L. Lundin, H. Toss, K. Svärdsudd (2011)
Randomized controlled trial of cognitive behavioral therapy vs standard treatment to prevent recurrent cardiovascular events in patients with coronary heart disease: Secondary Prevention in Uppsala Primary Health Care project (SUPRIM).
Archives of internal medicine, 171 2
G. Reeder, M. Lengyel, A. Tajik, J. Seward, H. Smith, G. Danielson (1981)
Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization.
Mayo Clinic proceedings, 56 2
J. Brugada, L. Aguinaga, L. Mont, A. Betriu, J. Mulet, G. Sanz (2001)
Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome.
Journal of the American College of Cardiology, 37 2
Hamm (2011)
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
Eur Heart J, 32
P. Thomsen, C. Jøns, M. Raatikainen, R. Joergensen, Juha Hartikainen, V. Virtanen, J. Boland, O. Anttonen, U. Gang, N. Hoest, L. Boersma, E. Platou, Daniel Becker, M. Messier, H. Huikuri (2010)
Long-Term Recording of Cardiac Arrhythmias With an Implantable Cardiac Monitor in Patients With Reduced Ejection Fraction After Acute Myocardial Infarction: The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study
Circulation, 122
K. Thygesen, J. Alpert, H. White (2007)
Universal definition of myocardial infarction.
Journal of the American College of Cardiology, 50 22
J. Mehilli, A. Kastrati, J. Dirschinger, J. Pache, M. Seyfarth, R. Blasini, D. Hall, F. Neumann, A. Schömig (2002)
Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention.
JAMA, 287 2
E. Hannan, Zaza Samadashvili, G. Walford, D. Holmes, A. Jacobs, N. Stamato, F. Venditti, Samin Sharma, S. King (2010)
Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
JACC. Cardiovascular interventions, 3 1
G. Amit, C. Cafri, H. Gilutz, R. Ilia, D. Zahger (2007)
Benefit of direct ambulance to coronary care unit admission of acute myocardial infarction patients undergoing primary percutaneous intervention.
International journal of cardiology, 119 3
A. Camm, P. Kirchhof, G. Lip, U. Schotten, I. Savelieva, S. Ernst, I. Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. Caterina, J. Sutter, A. Goette, B. Gorenek, M. Heldal, Stefan Hohloser, P. Kolh, J. Heuzey, P. Ponikowski, F. Rutten (2010)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
European heart journal, 31 19
J. Lønborg, H. Kelbæk, N. Vejlstrup, E. Jørgensen, S. Helqvist, K. Saunamäki, P. Clemmensen, L. Holmvang, M. Treiman, J. Jensen, T. Engstrøm (2010)
Cardioprotective Effects of Ischemic Postconditioning in Patients Treated With Primary Percutaneous Coronary Intervention, Evaluated by Magnetic Resonance
Circulation: Cardiovascular Interventions, 3
S. Yusuf, P. Held, C. Furberg (1991)
Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.
The American journal of cardiology, 67 15
J. Knot, P. Widimsky, W. Wijns, U. Stenestrand, S. Kristensen, A. Hof, F. Weidinger, M. Janzon, Bjarne Nörgaard, J. Soerensen, H. Wetering, K. Thygesen, Per-Adolf Bergsten, C. Digerfeldt, A. Potgieter, Nadav Tomer, J. Fajadet (2009)
How to set up an effective national primary angioplasty network: lessons learned from five European countries.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 5 3
G. Luca, M. Dirksen, C. Spaulding, H. Kelbaek, M. Schalij, L. Thuesen, Bas Hoeven, M. Vink, C. Kaiser, C. Musto, T. Chechi, G. Spaziani, L. Llera, V. Pasceri, E. Lorenzo, R. Violini, G. Cortese, H. Suryapranata, G. Stone (2012)
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
Archives of internal medicine, 172 8
M. Gierlotka, M. Gąsior, K. Wilczek, M. Hawranek, J. Szkodziński, Piotr Pączek, A. Lekston, Z. Kalarus, M. Zembala, L. Polonski (2011)
Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]).
The American journal of cardiology, 107 4
H. Huikuri, M. Cox, A. Interian, K. Kessler, F. Glicksman, A. Castellanos, R. Myerburg (1989)
Efficacy of intravenous propranolol for suppression of inducibility of ventricular tachyarrhythmias with different electrophysiologic characteristics in coronary artery disease.
The American journal of cardiology, 64 19
G. Montalescot, S. Wiviott, E. Braunwald, S. Murphy, C. Gibson, C. Mccabe, E. Antman (2009)
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
The Lancet, 373
R. Giraldez, J. Nicolau, R. Corbalán, E. Gurfinkel, Ú. Juárez, J. López-Sendón, A. Parkhomenko, P. Molhoek, Satishkumar Mohanavelu, D. Morrow, E. Antman (2007)
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis.
European heart journal, 28 13
(2007)
[ACC/AHA/ESC 2006 guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary].
Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 26 9
K. Allman, L. Shaw, R. Hachamovitch, J. Udelson (2002)
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.
Journal of the American College of Cardiology, 39 7
N. Abraham, M. Hlatky, E. Antman, Deepak Bhatt, D. Bjorkman, C. Clark, C. Furberg, David Johnson, Charles Kahi, L. Laine, K. Mahaffey, E. Quigley, J. Scheiman, L. Sperling, G. Tomaselli (2010)
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
The American Journal of Gastroenterology, 105
J. Berg, A. Hof, T. Dill, T. Heestermans, J. Werkum, A. Mosterd, G. Houwelingen, P. Koopmans, P. Stella, E. Boersma, C. Hamm (2010)
Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
Journal of the American College of Cardiology, 55 22
M. Cucherat, E. Bonnefoy, G. Trémeau (2007)
WITHDRAWN: Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
The Cochrane database of systematic reviews, 3
Zhengming Chen, Lixin Jiang, Yiping Chen, J. Xie, H. Pan, R. Peto, R. Collins, Lisheng Liu, Commit (2005)
Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial
The Lancet, 366
S. Solheim, I. Seljeflot, K. Lunde, R. Bjørnerheim, S. Aakhus, K. Forfang, H. Arnesen (2010)
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy.
The American journal of cardiology, 106 9
C. Terkelsen, J. Sørensen, M. Maeng, L. Jensen, H. Tilsted, S. Trautner, W. Vach, S. Johnsen, L. Thuesen, J. Lassen (2010)
System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention.
JAMA, 304 7
P. Steg, S. Jolly, S. Mehta, Rizwan Afzal, D. Xavier, H. Rupprecht, J. López-Sendón, A. Budaj, R. Diaz, Á. Avezum, P. Widimsky, S. Rao, S. Chrolavicius, Brandi Meeks, C. Joyner, J. Pogue, S. Yusuf (2010)
Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.
JAMA, 304 12
J. Mega, E. Braunwald, S. Wiviott, J. Bassand, Deepak Bhatt, C. Bode, P. Burton, Marc Cohen, N. Cook-Bruns, K. Fox, S. Goto, S. Murphy, A. Plotnikov, D. Schneider, Xiang Sun, F. Verheugt, C. Gibson (2012)
Rivaroxaban in patients with a recent acute coronary syndrome.
The New England journal of medicine, 366 1
E. Keeley, L. Hillis (1996)
Left Ventricular Mural Thrombus after Acute Myocardial Infarction
Clinical Cardiology, 19
Pitt (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
N Engl J Med, 348
D. Bono, M. Simoons, J. Tijssen, A. Arnold, A. Betriu, C. Burgersdijk, L. Bescós, E. Mueller, M. Pfisterer, F. Werf (1992)
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.
British Heart Journal, 67
P. Widimsky, M. Želízko, P. Janský, F. Toušek, F. Holm, M. Aschermann (2007)
The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry.
International journal of cardiology, 119 2
M. May, D. So, Richard Dionne, C. Glover, M. Froeschl, G. Wells, R. Davies, H. Sherrard, J. Maloney, J. Marquis, E. O’Brien, J. Trickett, P. Poirier, Sheila Ryan, A. Ha, Phil Joseph, M. Labinaz (2008)
A citywide protocol for primary PCI in ST-segment elevation myocardial infarction.
The New England journal of medicine, 358 3
S. Berkowitz, C. Granger, K. Pieper, Kerry Lee, J. Gore, M. Simoons, P. Armstrong, E. Topol, R. Califf (1997)
Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction
Circulation, 95
J. López-Sendón, I. Coma‐Canella, S. Alcasena, Jorge Seoane, C. Gamallo (1985)
Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2, and V3.
Journal of the American College of Cardiology, 6 6
M. Patel, R. Smalling, H. Thiele, H. Barnhart, Yi Zhou, P. Chandra, D. Chew, Marc Cohen, J. French, D. Perera, E. Ohman (2011)
Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial.
JAMA, 306 12
K. Fox, K. Carruthers, D. Dunbar, C. Graham, J. Manning, H. Raedt, I. Buysschaert, D. Lambrechts, F. Werf (2010)
Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).
European heart journal, 31 22
F. Werf, Jeroen Bax, A. Betriu, Carina Blomström-Lundqvist, Filippo Crea, Volkmar Falk, G. Filippatos, Keith Fox, Kurt Huber, Adnan Kastrati, A. Rosengren, P. Steg, M. Tubaro, F. Verheugt, F. Weidinger, Michael Weis, A. Vahanian, John Camm, R. Caterina, V. Dean, Kenneth Dickstein, C. Funck-Brentano, I. Hellemans, S. Kristensen, K. Mcgregor, U. Sechtem, S. Silber, M. Tendera, Petr Widimsky, J. Zamorano, Frank Aguirre, N. Al-Attar, Eduardo Alegría, F. Andreotti, W. Benzer, O. Breithardt, N. Danchin, C. Mario, Dariusz Dudek, D. Gulba, S. Halvorsen, Philipp Kaufmann, Ran Kornowski, G. Lip, Frans Rutten (2008)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
European heart journal, 29 23
J. Mehilli, A. Kastrati, S. Schulz, Stefan Früngel, S. Nekolla, W. Moshage, F. Dotzer, K. Huber, J. Pache, J. Dirschinger, M. Seyfarth, S. Martinoff, M. Schwaiger, A. Schömig (2009)
Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial
Circulation, 119
Zefeng Zhang, Jing Fang, C. Gillespie, Guijing Wang, Yuling Hong, P. Yoon (2012)
Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction.
The American journal of cardiology, 109 8
C. Grines, Robert Bonow, Donald Casey, Timothy Gardner, Peter Lockhart, D. Moliterno, Patrick O'Gara, Patrick Whitlow (2007)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D
Circulation, 115 6
G. Schwartz, A. Olsson, M. Ezekowitz, P. Ganz, M. Oliver, D. Waters, A. Zeiher, B. Chaitman (2001)
Atorvastatin for acute coronary syndromes.
JAMA, 286 5
J. Timmer, M. Hoekstra, M. Nijsten, I. Horst, J. Ottervanger, R. Slingerland, J. Dambrink, H. Bilo, F. Zijlstra, A. Hof (2011)
Prognostic Value of Admission Glycosylated Hemoglobin and Glucose in Nondiabetic Patients With ST-Segment–Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention
Circulation, 124
S. Mehta, J. Tanguay, J. Eikelboom, S. Jolly, C. Joyner, C. Granger, D. Faxon, H. Rupprecht, A. Budaj, Á. Avezum, P. Widimsky, P. Steg, J. Bassand, G. Montalescot, C. Macaya, G. Pasquale, K. Niemela, A. Ajani, H. White, S. Chrolavicius, P. Gao, K. Fox, S. Yusuf (2010)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
The Lancet, 376
M. Packer, A. Coats, M. Fowler, H. Katus, H. Krum, P. Mohacsi, J. Rouleau, M. Tendera, A. Castaigne, E. Roecker, M. Schultz, D. DeMets (2001)
Effect of carvedilol on survival in severe chronic heart failure.
The New England journal of medicine, 344 22
K. Thygesen, Joseph Alpert, H. White, Allan Jaffe, F. Apple, M. Galvani, H. Katus, L. Newby, J. Ravkilde, B. Chaitman, P. Clemmensen, M. Dellborg, H. Hod, P. Porela, Richard Underwood, Jeroen Bax, G. Beller, Robert Bonow, E. Wall, J. Bassand, W. Wijns, T. Ferguson, P. Steg, B. Uretsky, David Williams, P. Armstrong, E. Antman, Keith Fox, C. Hamm, E. Ohman, M. Simoons, P. Poole‐Wilson, E. Gurfinkel, J. López-Sendón, P. Pais, S. Mendis, Jun-Ren Zhu, L. Wallentin, F. Fernández‐Avilés, Kim Fox, A. Parkhomenko, S. Priori, M. Tendera, L. Voipio‐Pulkki, A. Vahanian, A. Camm, R. Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. Kristensen, K. Mcgregor, U. Sechtem, S. Silber, Petr Widimsky, J. Zamorano, J. Morais, S. Brener, Robert Harrington, David Morrow, M. Lim, M. Martínez‐Ríos, Stephen Steinhubl, G. Levine, W. Gibler, David Goff, M. Tubaro, Dariusz Dudek, N. Al-Attar (2007)
Universal definition of myocardial infarction.
European Heart Journal, 28
R. Luepker, J. Raczynski, S. Osganian, R. Goldberg, J. Finnegan, J. Hedges, D. Goff, M. Eisenberg, J. Zapka, H. Feldman, D. Labarthe, P. McGovern, C. Cornell, M. Proschan, D. Simons-Morton (2000)
Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial.
JAMA, 284 1
C. Deakin, J. Nolan, J. Soar, K. Sunde, R. Koster, Gary Smith, G. Perkins (2010)
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support.
Resuscitation, 81 10
P. Vlaar, K. Mahmoud, D. Holmes, G. Valkenhoef, H. Hillege, Iwan Horst, F. Zijlstra, B. Smet (2011)
Clinical ResearchInterventional CardiologyCulprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction: A Pairwise and Network Meta-Analysis
Journal of the American College of Cardiology, 58
K. Dickstein, P. Vardas, A. Auricchio, J. Daubert, C. Linde, J. McMurray, P. Ponikowski, S. Priori, R. Sutton, D. Veldhuisen, A. Vahanian, Jeroen Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, Richard Hobbs, P. Kearney, T. McDonagh, B. Popescu, Željko Reiner, U. Sechtem, P. Sirnes, M. Tendera, P. Vardas, Petr Widimsky, S. Anker, J. Blanc, M. Gasparini, A. Hoes, Carsten Israel, Z. Kalarus, B. Merkely, K. Swedberg, A. Camm (2011)
2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure
J. Perlman, J. Wyllie, J. Kattwinkel, D. Atkins, L. Chameides, J. Goldsmith, R. Guinsburg, M. Hazinski, C. Morley, S. Richmond, W. Simon, N. Singhal, E. Szyld, M. Tamura, S. Velaphi (2010)
Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
Circulation, 122 16 Suppl 2
Sayuri Friedland, M. Eisenberg, A. Shimony (2011)
Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome.
The American journal of cardiology, 108 9
P. Steg, S. James, R. Harrington, D. Ardissino, Richard Becker, Christopher Cannon, H. Emanuelsson, A. Finkelstein, S. Husted, H. Katus, J. Kilhamn, Sylvia Olofsson, Robert Storey, W. Weaver, L. Wallentin (2010)
Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis
Circulation, 122
R. Jeger, C. Tseng, J. Hochman, E. Bates (2006)
Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock--a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry.
American heart journal, 152 4
R. West, Dee Jones, A. Henderson (2011)
Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction
Heart, 98
J. Piccini, P. Schulte, K. Pieper, R. Mehta, H. White, F. Werf, D. Ardissino, R. Califf, C. Granger, E. Ohman, J. Alexander (2009)
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction*
Critical Care Medicine, 39
M. Dennis (1996)
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
The Lancet, 348
O. Topaz, A. Taylor (1992)
Interventricular septal rupture complicating acute myocardial infarction: from pathophysiologic features to the role of invasive and noninvasive diagnostic modalities in current management.
The American journal of medicine, 93 6
P. Steg, E. Bonnefoy, S. Chabaud, F. Lapostolle, P. Dubien, P. Cristofini, A. Leizorovicz, P. Touboul (2003)
Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial
Circulation: Journal of the American Heart Association, 108
D. Capodanno, A. Patel, K. Dharmashankar, J. Ferreiro, Masafumi Ueno, Murali Kodali, S. Tomasello, P. Capranzano, N. Seecheran, Andrew Darlington, A. Tello-Montoliu, Bhaloo Desai, T. Bass, D. Angiolillo (2011)
Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease
Circulation: Cardiovascular Interventions, 4
P. Chevalier, H. Burri, F. Fahrat, M. Cucherat, O. Jegaden, J. Obadia, G. Kirkorian, P. Touboul (2004)
Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgitation.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 26 2
Perk (2012)
The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Eur Heart J, 33
Arman Askari, M. Shishehbor, Matthew Kaminski, Michael Riley, A. Hsu, A. Lincoff (2009)
The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUSTO) V.
American heart journal, 158 2
M. May, G. Wells, M. Labinaz, R. Davies, M. Turek, D. Leddy, J. Maloney, Tim McKibbin, B. Quinn, R. Beanlands, C. Glover, J. Marquis, E. O’Brien, W. Williams, L. Higginson (2005)
Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study).
Journal of the American College of Cardiology, 46 3
R. Storey, R. Becker, R. Harrington, S. Husted, S. James, F. Cools, P. Steg, N. Khurmi, H. Emanuelsson, A. Cooper, Richard Cairns, C. Cannon, L. Wallentin (2011)
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes.
European heart journal, 32 23
Gusto Investigators (1993)
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
The New England journal of medicine, 329 22
H. Bøtker, R. Kharbanda, M. Schmidt, M. Bøttcher, A. Kaltoft, C. Terkelsen, K. Munk, N. Andersen, T. Hansen, S. Trautner, J. Lassen, E. Christiansen, L. Krusell, S. Kristensen, L. Thuesen, S. Nielsen, M. Rehling, H. Sørensen, A. Redington, T. Nielsen (2010)
Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial
The Lancet, 375
D. Brieger, K. Eagle, S. Goodman, P. Steg, A. Budaj, Kami White, Mph, G. Montalescot, Canada Bichat, France Paris, Grochowski Hospital, Warsaw, Poland (2004)
Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events.
Chest, 126 2
Duane Pinto, Paul Frederick, Anjan Chakrabarti, Ajay Kirtane, Edward Ullman, Andre Dejam, Dave Miller, Timothy Henry, C. Gibson (2011)
Benefit of Transferring ST-Segment–Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase
Circulation, 124
B. Heran, J. Chen, S. Ebrahim, T. Moxham, N. Oldridge, K. Rees, D. Thompson, R. Taylor (2011)
Exercise-based cardiac rehabilitation for coronary heart disease.
The Cochrane database of systematic reviews, 7
E. Bonnefoy, P. Steg, F. Boutitie, P. Dubien, F. Lapostolle, J. Roncalli, F. Dissait, G. Vanzetto, A. Leizorowicz, G. Kirkorian, C. Mercier, E. Mcfadden, P. Touboul (2009)
Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up.
European heart journal, 30 13
G. Luca, H. Suryapranata, A. Hof, M. Boer, J. Hoorntje, J. Dambrink, A. Gosselink, J. Ottervanger, F. Zijlstra (2004)
Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty: Implications for Early Discharge
Circulation: Journal of the American Heart Association, 109
G. Stone, B. Brodie, J. Griffin, C. Costantini, M. Morice, F. Goar, P. Overlie, J. Popma, J. McDonnell, Denise Jones, W. O’Neill, C. Grines (1999)
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial.
Circulation, 99 12
P. Steg, S. Mehta, J. Jukema, G. Lip, C. Gibson, F. Kovář, P. Kala, A. García-Hernandez, R. Renfurm, C. Granger (2011)
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
European Heart Journal, 32
L. Mandelzweig, A. Battler, V. Boyko, H. Bueno, N. Danchin, G. Filippatos, A. Gitt, D. Hasdai, Y. Hasin, J. Marrugat, F. Werf, L. Wallentin, S. Behar (2006)
The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004.
European heart journal, 27 19
M. Picard, R. Davidoff, L. Sleeper, L. Mendes, C. Thompson, V. Džavík, R. Steingart, K. Gin, H. White, J. Hochman (2003)
Echocardiographic Predictors of Survival and Response to Early Revascularization in Cardiogenic Shock
Circulation: Journal of the American Heart Association, 107
Petr Widimsky, T. Buděšínský, D. Voráč, L. Groch, M. Želízko, M. Aschermann, M. Branny, J. Šťásek, P. Formánek (2003)
Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.
European heart journal, 24 1
M. Shlipak, William Lyons, A. Go, T. Chou, G. Evans, W. Browner (1999)
Should the electrocardiogram be used to guide therapy for patients with left bundle-branch block and suspected myocardial infarction?
JAMA, 281 8
R. Diaz, Abhinav Goyal, S. Mehta, Rizwan Afzal, D. Xavier, P. Pais, S. Chrolavicius, Jun Zhu, K. Kazmi, Li-sheng Liu, A. Budaj, M. Zubaid, Á. Avezum, M. Ruda, S. Yusuf (2007)
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
JAMA, 298 20
A. Kastrati, A. Dibra, C. Spaulding, G. Laarman, M. Menichelli, M. Valgimigli, E. Lorenzo, C. Kaiser, I. Tierala, J. Mehilli, M. Seyfarth, O. Varenne, M. Dirksen, G. Percoco, A. Varricchio, U. Pittl, M. Syvänne, M. Suttorp, R. Violini, A. Schömig (2007)
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.
European heart journal, 28 22
J. Hochman, L. Sleeper, H. White, V. Džavík, S. Wong, V. Menon, J. Webb, Richard Steingart, Michael Picard, M. Menegus, J. Boland, T. Sanborn, Christopher Buller, Sharada Modur, Robert Forman, Patrice Desvigne-Nickens, A. Jacobs, James Slater, Thierry Lejemtel, St 's (2001)
One-year survival following early revascularization for cardiogenic shock.
JAMA, 285 2
K. DeVault (2011)
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
Yearbook of Medicine, 2011
M. Gilard, B. Arnaud, J. Cornily, G. Gal, K. Lacut, G. Calvez, J. Mansourati, D. Mottier, J. Abgrall, J. Boschat (2008)
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
Journal of the American College of Cardiology, 51 3
Noel Merz, R. Bonow, G. Sopko, R. Balaban, R. Cannon, D. Gordon, M. Hand, S. Hayes, Jannet Lewis, Terry Long, T. Manolio, A. Maseri, E. Nabel, P. Nickens, C. Pepine, R. Redberg, J. Rossouw, H. Selker, L. Shaw, D. Waters (2004)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: executive summary.
Circulation, 109 6
E. Sgarbossa, S. Pinski, Alejandro Barbagelata, D. Underwood, K. Gates, E. Topol, R. Califf, G. Wagner (1996)
Electrocardiographic Diagnosis of Evolving Acute Myocardial Infarction in the Presence of Left Bundle-Branch Block
The New England Journal of Medicine, 334
R. Goldberg, F. Spencer, J. Gore, D. Lessard, J. Yarzebski (2009)
Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective
Circulation, 119
S. James, P. Aylward, Kristen Buck, C. Cannon, J. Cornel, R. Harrington (2010)
Coronary Heart Disease Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function Results From the Platelet Inhibition and Patient Outcomes (PLATO) Trial
P. Nielsen, C. Terkelsen, T. Nielsen, L. Thuesen, L. Krusell, P. Thayssen, H. Kelbaek, U. Abildgaard, A. Villadsen, H. Andersen, M. Maeng (2011)
System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).
The American journal of cardiology, 108 6
M. Kosiborod, Darren Mcguire (2010)
Glucose-lowering targets for patients with cardiovascular disease: focus on inpatient management of patients with acute coronary syndromes.
Circulation, 122 25
A. Porter, Hadas Kandalker, Z. Iakobishvili, A. Sagie, S. Imbar, A. Battler, D. Hasdai (2005)
Left ventricular mural thrombus after anterior ST-segment-elevation acute myocardial infarction in the era of aggressive reperfusion therapy – still a frequent complication
Coronary Artery Disease, 16
M. Sabatine, C. Cannon, C. Gibson, J. López-Sendón, G. Montalescot, P. Théroux, M. Claeys, F. Cools, K. Hill, A. Skene, C. Mccabe, E. Braunwald (2005)
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
The New England journal of medicine, 352 12
M. Cucherat, E. Bonnefoy, G. Trémeau (2003)
Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
The Cochrane database of systematic reviews, 3
Ashkan M, A. Afshin, M. Forouzanfar, M. Reitsma, P. Sur, Kara Estep, Alex Lee, L. Marczak, A. Mokdad, M. Moradi-Lakeh, M. Naghavi, Joseph Salama, T. Vos, K. Abate, C. Abbafati, M. Ahmed, Z. Al‐Aly, A. Alkerwi, Rajaa Al-Raddadi, Azmeraw Amare, A. Amegah, E. Amini, A. Amberbir, S. Amrock, R. Anjana, J. Ärnlöv, H. Asayesh, A. Banerjee, A. Barać, Estifanos Baye, D. Bennett, Masako Berger, A. Beyene, S. Biadgilign, S. Biryukov, E. Bjertness, Ismael Campos-Nonato, J. Carrero, P. Cecílio, Kelly Cercy, Liliana Ciobanu, Leslie Cornaby, S. Damtew, L. Dandona, R. Dandona, S. Dharmaratne, B. Duncan, B. Eshrati, A. Esteghamati, V. Feigin, João Fernandes, Thomas Fürst, T. Gebrehiwot, Audra Gold, P. Gona, A. Goto, T. Habtewold, K. Hadush, N. Hafezi-Nejad, S. Hay, M. Schmidt, F. Islami, D. Boneya, R. Kamal, A. Kasaeian, S. Katikireddi, A. Kengne, C. Kesavachandran, Y. Khader, Y. Khang, J. Khubchandani, Daniel Kim, Y. Kim, Y. Kinfu, S. Kosen, Tiffany Ku, B. Defo, G. Kumar, H. Larson, M. Leinsalu, Xiaofeng Liang, Stephen Lim, Patrick Liu, Alan Lopez, R. Lozano, A. Majeed, R. Malekzadeh, D. Malta, M. Mazidi, C. McAlinden, S. Mcgarvey, Desalegn Mengiste, Z. Zenebe, G. Mensah, Gert Mensink, H. Mezgebe, E. Mirrakhimov, U. Mueller, Jean Noubian, C. Obermeyer, F. Ogbo, M. Owolabi, G. Patton, F. Pourmalek, M. Qorbani, Anwar Rafay, R. Rai, C. Ranabhat, Nikolas Reinig, S. Safiri, J. Salomon, J. Sanabria, I. Santos, B. Sartorius, M. Sawhney, J. Schmidhuber, A. Schutte, S. Sepanlou, Moretza Shamsizadeh, S. Sheikhbahaei, Min-Jeong Shin, R. Shiri, I. Shiue, H. Shore, D. Silva, J. Silverberg, J. Singh, S. Stranges, S. Swaminathan, R. Tabarés-Seisdedos, Fentaw Tadese, B. Tedla, B. Tegegne, A. Terkawi, J. Thakur, M. Tonelli, R. Topor-Madry, S. Tyrovolas, K. Ukwaja, O. Uthman, Masoud Vaezghasemi, T. Vasankari, V. Vlassov, S. Vollset, E. Weiderpass, A. Werdecker, Joshua Wesana, R. Westerman, Y. Yano, N. Yonemoto, G. Yonga, Z. Zaidi, B. Zipkin, C. Murray (2002)
Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.
The New England journal of medicine, 346 8
Y. Hasin, N. Danchin, G. Filippatos, M. Heras, U. Janssens, J. Leor, M. Nahir, A. Parkhomenko, K. Thygesen, M. Tubaro, L. Wallentin, I. Zakke (2005)
Recommendations for the structure, organization, and operation of intensive cardiac care units.
European heart journal, 26 16
Kerry Lee, L. Woodlief, E. Topol, W. Weaver, A. Betriu, J. Col, M. Simoons, P. Aylward, F. Werf, R. Califf (1995)
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators.
Circulation, 91 6
P. Kligfield (1995)
Primary angioplasty in myocardial infarction.
British Heart Journal, 73
S. D'Souza, M. Mamas, D. Fraser, F. Fath-ordoubadi (2011)
Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.
European heart journal, 32 8
L. Wallentin, P. Goldstein, P. Armstrong, C. Granger, A. Adgey, H. Arntz, K. Bogaerts, T. Danays, B. Lindahl, M. Mäkijärvi, F. Verheugt, F. Werf (2003)
Efficacy and Safety of Tenecteplase in Combination With the Low-Molecular-Weight Heparin Enoxaparin or Unfractionated Heparin in the Prehospital Setting: The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS Randomized Trial in Acute Myocardial Infarction
Circulation: Journal of the American Heart Association, 108
R. Beanlands, G. Nichol, E. Huszti, D. Humen, N. Racine, M. Freeman, K. Gulenchyn, L. Garrard, R. deKemp, Ann Guo, T. Ruddy, F. Bénard, A. Lamy, R. Iwanochko (2007)
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).
Journal of the American College of Cardiology, 50 20
G. Belliard, E. Catez, C. Charron, V. Caillé, P. Aegerter, O. Dubourg, F. Jardin, A. Vieillard-Baron (2007)
Efficacy of therapeutic hypothermia after out-of-hospital cardiac arrest due to ventricular fibrillation.
Resuscitation, 75 2
A. Bahekar, Mukesh Singh, Sarabjeet Singh, R. Bhuriya, K. Ahmad, S. Khosla, R. Arora (2012)
Cardiovascular Outcomes Using Intra-Aortic Balloon Pump in High-Risk Acute Myocardial Infarction With or Without Cardiogenic Shock
Journal of Cardiovascular Pharmacology and Therapeutics, 17
T. Svilaas, P. Vlaar, I. Horst, G. Diercks, B. Smet, A. Heuvel, R. Anthonio, G. Jessurun, E. Tan, A. Suurmeijer, F. Zijlstra (2008)
Thrombus aspiration during primary percutaneous coronary intervention.
The New England journal of medicine, 358 6
B. Nallamothu, H. Krumholz, D. Ko, K. Labresh, S. Rathore, M. Roe, L. Schwamm (2007)
Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Gaps, Barriers, and Implications
Circulation, 116
F. Werf, H. Barron, P. Armstrong, C. Granger, S. Berioli, G. Barbash, K. Pehrsson, F. Verheugt, Jürgen Meyer, A. Betriu, Califf Rm, Xuri Li, N. Fox (2001)
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA.
European heart journal, 22 24
Gissi-Prevenzione Investigators (1999)
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial
The Lancet, 354
M. Pfeffer, E. Braunwald, L. Moye, L. Basta, E. Brown, T. Cuddy, B. Davis, E. Geltman, S. Goldman, G. Flaker, M. Klein, G. Lamas, M. Packer, J. Rouleau, J. Rouleau, J. Rutherford, J. Wertheimer, C. Hawkins (1992)
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.
The New England journal of medicine, 327 10
Douglas Lee, Lawrence Green, Peter Liu, P. Dorian, D. Newman, F. Grant, J. Tu, D. Alter (2003)
Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis.
Journal of the American College of Cardiology, 41 9
H. Herrmann, Jiandong Lu, B. Brodie, P. Armstrong, G. Montalescot, A. Betriu, F. Neuman, M. Effron, E. Barnathan, E. Topol, S. Ellis (2009)
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.
JACC. Cardiovascular interventions, 2 10
U. Zeymer, A. Margenet, M. Haude, C. Bode, J. Lablanche, H. Heuer, R. Schröder, S. Kropff, R. Bourkaib, N. Banik, R. Zahn, E. Teiger (2010)
Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.
Journal of the American College of Cardiology, 56 6
A. Åkerblom, S. James, M. Koutouzis, B. Lagerqvist, U. Stenestrand, B. Svennblad, J. Oldgren (2010)
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
Journal of the American College of Cardiology, 56 6
L. Mauri, D. Kereiakes, S. Normand, S. Wiviott, D. Cohen, D. Holmes, S. Bangalore, D. Cutlip, M. Pencina, J. Massaro (2010)
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent
American heart journal, 160 6
B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, Steve Hurley, J. Kleiman, M. Gatlin (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
The New England journal of medicine, 348 14
G. Bardy, Kerry Lee, D. Mark, J. Poole, D. Packer, R. Boineau, M. Domanski, C. Troutman, Jill Anderson, G. Johnson, S. McNulty, N. Clapp-Channing, L. Davidson-Ray, Elizabeth Fraulo, D. Fishbein, R. Luceri, J. Ip (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
The New England journal of medicine, 352 3
J. Sheu, Tzu-hsien Tsai, F. Lee, Hsiu‐Yu Fang, Cheuk-Kwan Sun, S. Leu, Cheng‐Hsu Yang, Shyh-Ming Chen, C. Hang, Y. Hsieh, Chien‐Jen Chen, Chiung‐Jen Wu, H. Yip (2010)
Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock
Critical Care Medicine, 38
G. Luca, F. Bellandi, K. Huber, M. Noc, A. Petronio, H. Arntz, M. Maioli, H. Gabriel, S. Zorman, M. Carlo, T. Rakowski, M. Gyöngyösi, D. Dudek (2011)
Early glycoprotein IIb‐IIIa inhibitors in primary angioplasty‐abciximab long‐term results (EGYPT‐ALT) cooperation: individual patient’s data meta‐analysis
Journal of Thrombosis and Haemostasis, 9
J. Dörler, M. Edlinger, H. Alber, J. Altenberger, W. Benzer, G. Grimm, K. Huber, O. Pachinger, H. Schuchlenz, P. Siostrzonek, G. Zenker, F. Weidinger (2011)
Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
European heart journal, 32 23
Farrukh Hussain, R. Philipp, R. Ducas, Jason Elliott, V. Džavík, D. Jassal, J. Tam, D. Roberts, P. Garber, J. Ducas (2011)
The ability to achieve complete revascularization is associated with improved in‐hospital survival in cardiogenic shock due to myocardial infarction: Manitoba cardiogenic shock registry investigators
Catheterization and Cardiovascular Interventions, 78
P. Jabre, V. Roger, M. Murad, A. Chamberlain, L. Prokop, F. Adnet, X. Jouven (2011)
Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis
Circulation, 123
P. Vlaar, T. Svilaas, I. Horst, G. Diercks, M. Fokkema, B. Smet, A. Heuvel, R. Anthonio, G. Jessurun, E. Tan, A. Suurmeijer, F. Zijlstra (2008)
Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study
The Lancet, 371
H. Ting, H. Krumholz, E. Bradley, D. Cone, J. Curtis, B. Drew, J. Field, W. French, W. Gibler, D. Goff, A. Jacobs, B. Nallamothu, R. O’Connor, J. Schuur (2008)
Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursi
Circulation, 118 10
L. Newby, V. Hasselblad, P. Armstrong, F. Werf, D. Mark, H. White, E. Topol, R. Califf (2003)
Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making.
European heart journal, 24 2
F. Fernández‐Avilés, J. Alonso, A. Castro‐Beiras, N. Vázquez, Jesús Blanco, J. Alonso-Briales, Juan López-Mesa, F. Fernández-Vázquez, I. Calvo, L. Martínez-Elbal, J. Román, Benigo Ramos (2004)
Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial
The Lancet, 364
M. Sutton, M. Pfeffer, T. Plappert, J. Rouleau, L. Moye, G. Dagenais, G. Lamas, M. Klein, B. Sussex, S. Goldman (1994)
Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril
Journal of Diagnostic Medical Sonography, 10
H. Gwon, J. Hahn, Kyung-Woo Park, Y. Song, I. Chae, D. Lim, K. Han, Jin‐Ho Choi, Seung‐Hyuk Choi, Hyun-Jae Kang, B. Koo, T. Ahn, J. Yoon, M. Jeong, T. Hong, W. Chung, Y. Choi, S. Hur, H. Kwon, D. Jeon, Byung-Ok Kim, S. Park, N. Lee, H. Jeon, Y. Jang, Hyo‐Soo Kim (2012)
Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study
Circulation, 125
E. Ohman, J. Nanas, R. Stomel, M. Leesar, D. Nielsen, Daniel O’Dea, F. Rogers, D. Harber, M. Hudson, Elizabeth Fraulo, L. Shaw, Kerry Lee (2005)
Thrombolysis and Counterpulsation to Improve Survival in Myocardial Infarction Complicated by Hypotension and Suspected Cardiogenic Shock or Heart Failure: Results of the TACTICS Trial
Journal of Thrombosis and Thrombolysis, 19
Duane Pinto, A. Kirtane, B. Nallamothu, S. Murphy, D. Cohen, R. Laham, D. Cutlip, E. Bates, P. Frederick, David Miller, J. Carrozza, E. Antman, C. Cannon, C. Gibson (2006)
Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy
Circulation, 114
K. Dickstein, J. Kjekshus (2002)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial
The Lancet, 360
J. Madsen, P. Grande, K. Saunamäki, P. Thayssen, E. Kassis, Eriksen Uh, K. Rasmussen, S. Haunsø, T. Nielsen, T. Haghfelt, P. Fritz-Hansen, E. Hjelms, P. Paulsen, P. Alstrup, H. Arendrup, U. Niebuhr-Jørgensen, L. Andersen (1997)
Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction.
Circulation, 96 3
M. Link, D. Atkins, R. Passman, H. Halperin, R. Samson, Roger White, M. Cudnik, M. Berg, P. Kudenchuk, R. Kerber (2010)
Part 6: electrical therapies: automated external defibrillators, defibrillation, cardioversion, and pacing: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Circulation, 122 18 Suppl 3
A. Turpie, J. Robinson, Daniel Doyle, A. Mulji, G. Mishkel, B. Sealey, J. Cairns, Leslie Skingley, J. Hirsh, M. Gent (1989)
Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.
The New England journal of medicine, 320 6
The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators
N Engl J Med, 329
A. Engström, M. Vis, B. Bouma, R. Brink, J. Baan, B. Claessen, W. Kikkert, K. Sjauw, M. Meuwissen, K. Koch, R. Winter, J. Tijssen, J. Piek, J. Henriques (2010)
Right ventricular dysfunction is an independent predictor for mortality in ST‐elevation myocardial infarction patients presenting with cardiogenic shock on admission
European Journal of Heart Failure, 12
T. Meine, M. Patel, J. Washam, P. Pappas, J. Jollis (2005)
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes.
The American journal of cardiology, 95 8
M. Bartnik, L. Rydén, R. Ferrari, K. Malmberg, K. Pyörälä, M. Simoons, E. Standl, J. Soler‐Soler, J. Ohrvik (2004)
The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.
European heart journal, 25 21
J. Alexander, R. Lopes, S. James, R. Kilaru, Yaohua He, Puneet Mohan, Deepak Bhatt, S. Goodman, F. Verheugt, M. Flather, K. Huber, Danny Liaw, S. Husted, J. López-Sendón, R. Caterina, P. Janský, H. Darius, D. Vinereanu, J. Cornel, F. Cools, D. Atar, J. Leiva-Pons, M. Keltai, H. Ogawa, P. Pais, A. Parkhomenko, W. Rużyłło, R. Diaz, H. White, M. Ruda, M. Geraldes, J. Lawrence, R. Harrington, L. Wallentin (2011)
Apixaban with antiplatelet therapy after acute coronary syndrome.
The New England journal of medicine, 365 8
H. White, E. Braunwald, S. Murphy, A. Jacob, N. Gotcheva, L. Polonetsky, E. Antman (2007)
Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.
European heart journal, 28 9
Caroline Milton, Prashanthan Sanders, P. Steele (2001)
For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt
M. Anselmino, J. Öhrvik, K. Malmberg, L. Rydén (2007)
Abstract 3735: Glucose Lowering Therapy in Post Myocardial Infarction Patients with Diabetes - is Insulin Safe? A report from the Euro Heart Survey on Diabetes and the Heart
Circulation, 116
P. Staat, G. Rioufol, C. Piot, Y. Cottin, T. Cung, I. L'huillier, J. Aupetit, E. Bonnefoy, G. Finet, X. André‐Fouët, M. Ovize (2005)
Postconditioning the Human Heart
Circulation, 112
A. Hof, J. Berg, T. Heestermans, T. Dill, R. Funck, Wouter Werkum, J. Dambrink, H. Suryapranata, G. Houwelingen, J. Ottervanger, P. Stella, E. Giannitsis, C. Hamm (2008)
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
The Lancet, 372
S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais (2000)
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
The New England Journal of Medicine, 342
Stephen Ellis, Expedito Silva, G. Heyndrickx, J. Talley, C. Cernigliaro, G. Steg, C. Spaulding, M. Nobuyoshi, R. Erbel, C. Vassanelli, E. Topol (1994)
Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction.
Circulation, 90 5
E. Standl, G. Berghe (2007)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary
Aaron From, P. Best, R. Lennon, C. Rihal, A. Prasad (2010)
Acute myocardial infarction due to left circumflex artery occlusion and significance of ST-segment elevation.
The American journal of cardiology, 106 8
G. Stone, B. Witzenbichler, G. Guagliumi, J. Peruga, B. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B. Gersh, S. Pocock, G. Dangas, S. Wong, M. Fahy, H. Parise, R. Mehran (2011)
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial
The Lancet, 377
Azriel Osherov, Michal Borovik-Raz, D. Aronson, Y. Agmon, M. Kapeliovich, A. Kerner, E. Grenadier, H. Hammerman, E. Nikolsky, A. Roguin (2009)
Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era.
American heart journal, 157 6
G. Dangas, A. Caixeta, R. Mehran, H. Parise, A. Lansky, Ecaterina Cristea, B. Brodie, B. Witzenbichler, G. Guagliumi, J. Peruga, D. Dudek, Martin Möeckel, G. Stone (2011)
Frequency and Predictors of Stent Thrombosis After Percutaneous Coronary Intervention in Acute Myocardial Infarction
Circulation, 123
J. Perk, G. Backer, H. Gohlke, I. Graham, Željko Reiner, W. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cífková, C. Deaton, S. Ebrahim, Miles Fisher, G. Germano, R. Hobbs, A. Hoes, Ş. Karadeniz, A. Mezzani, E. Prescott, L. Rydén, M. Scherer, M. Syvänne, W. Reimer, C. Vrints, D. Wood, J. Zamorano, F. Zannad, Developed Rehabilitation (2012)
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
International Journal of Behavioral Medicine, 19
K. Kern, Ossama Rahman (2009)
Emergent percutaneous coronary intervention for resuscitated victims of out‐of‐hospital cardiac arrest
Catheterization and Cardiovascular Interventions, 75
P. Giannuzzi, P. Temporelli, R. Marchioli, A. Maggioni, G. Balestroni, V. Ceci, C. Chieffo, M. Gattone, R. Griffo, C. Schweiger, L. Tavazzi, S. Urbinati, F. Valagussa, D. Vanuzzo (2008)
Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
Archives of internal medicine, 168 20
Christian Spaulding, L. Joly, Alain Rosenberg, M. Monchi, S. Weber, J. Dhainaut, P. Carli (1997)
Immediate coronary angiography in survivors of out-of-hospital cardiac arrest.
The New England journal of medicine, 336 23
E. Nabel, H. Selker, R. Califf, J. Canto, J. Cao, Patrice Desvigne-Nikkens, R. Goldberg, J. Finnegan, V. Vaccarino, R. Virmani (2004)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 3: diagnosis and treatment of acute cardiac ischemia: gender issues.
Circulation, 109 6
P. Armstrong, A. Gershlick, P. Goldstein, R. Wilcox, T. Danays, E. Bluhmki, F. Werf (2010)
The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study.
American heart journal, 160 1
F. Borgia, S. Goodman, S. Halvorsen, W. Cantor, F. Piscione, M. May, F. Fernández‐Avilés, P. Sánchez, K. Dimopoulos, B. Scheller, P. Armstrong, C. Mario (2010)
Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis.
European heart journal, 31 17
P. Poole-Wilson, J. Lubsen, B. Kirwan, F. Dalen, G. Wagener, N. Danchin, H. Just, K. Fox, S. Pocock, Tim Clayton, M. Motro, John Parker, M. Bourassa, Anthony Dart, P. Hildebrandt, A. Hjalmarson, A. Johannes, Kragten, G. Molhoek, J. Otterstad, R. Seabra‐Gomes, J. Soler‐Soler, S. Weber (2004)
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial
The Lancet, 364
James (2010)
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial
Circulation, 122
H. Dalal, A. Zawada, K. Jolly, T. Moxham, Rod Taylor (2010)
Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis
The BMJ, 340
K. Alexander, A. Chen, M. Roe, L. Newby, C. Gibson, Nancy Allen-LaPointe, C. Pollack, W. Gibler, E. Ohman, E. Peterson (2005)
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.
JAMA, 294 24
M. Pfeffer, J. McMurray, E. Velazquez, J. Rouleau, L. Køber, A. Maggioni, S. Solomon, K. Swedberg, F. Werf, H. White, J. Leimberger, M. Henis, Susan Edwards, S. Zelenkofske, M. Sellers, R. Califf (2003)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
The New England journal of medicine, 349 20
M. Cavender, Sarah Milford-Beland, M. Roe, E. Peterson, W. Weintraub, S. Rao (2009)
Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry).
The American journal of cardiology, 104 4
E. Bradley, J. Herrin, Yongfei Wang, B. Barton, Tashonna Webster, J. Mattera, S. Roumanis, J. Curtis, B. Nallamothu, D. Magid, R. McNamara, J. Parkosewich, J. Loeb, H. Krumholz (2006)
Strategies for reducing the door-to-balloon time in acute myocardial infarction.
The New England journal of medicine, 355 22
P. Widimsky, J. Fajadet, N. Danchin, W. Wijns (2009)
"Stent 4 Life" targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac Care.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 4 5
K. Fox, F. Anderson, O. Dabbous, P. Steg, J. López-Sendón, F. Werf, A. Budaj, E. Gurfinkel, S. Goodman, D. Brieger (2005)
Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE)
Heart, 93
P. Poole‐Wilson, K. Swedberg, J. Cleland, A. Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W. Remme, C. Torp-Pedersen, A. Scherhag, A. Skene (2003)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
The Lancet, 362
H. Kelbaek, C. Terkelsen, S. Helqvist, J. Lassen, P. Clemmensen, L. Kløvgaard, A. Kaltoft, T. Engstrøm, H. Bøtker, K. Saunamäki, L. Krusell, E. Jørgensen, H. Hansen, E. Christiansen, J. Ravkilde, L. Køber, K. Kofoed, L. Thuesen (2008)
Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.
Journal of the American College of Cardiology, 51 9
L. Morrison, P. Verbeek, Andrew McDonald, Bruce Sawadsky, D. Cook (2000)
Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis.
JAMA, 283 20
Ryden (2007)
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur Heart J, 28
CIBIS-II Committees (1999)
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
The Lancet, 353
M. Valgimigli, G. Biondi-Zoccai, M. Tebaldi, A. Hof, G. Campo, C. Hamm, J. Berg, L. Bolognese, F. Saia, G. Danzi, C. Briguori, E. Okmen, S. King, D. Moliterno, E. Topol (2010)
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials.
European heart journal, 31 1
F. Spencer, D. Lessard, J. Gore, Jorge Yarzebski, R. Goldberg (2004)
Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective.
Archives of internal medicine, 164 7
P. Steg, J. Cambou, P. Goldstein, E. Durand, P. Sauval, Z. Kadri, D. Blanchard, J. Lablanche, P. Guéret, Y. Cottin, J. Juliard, G. Hanania, L. Vaur, N. Danchin (2006)
Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry
Heart, 92
H. White (2000)
Thrombolytic therapy in the elderly
The Lancet, 356
J. McMullan, William Hinckley, J. Bentley, Todd Davis, G. Fermann, Matthew Gunderman, K. Hart, W. Knight, C. Lindsell, Chris Miller, A. Shackleford, W. Gibler (2012)
Ground emergency medical services requests for helicopter transfer of ST-segment elevation myocardial infarction patients decrease medical contact to balloon times in rural and suburban settings.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 19 2
K. Fox, O. Dabbous, R. Goldberg, K. Pieper, K. Eagle, F. Werf, �lvaro Avezum, S. Goodman, M. Flather, F. Anderson, C. Granger (2006)
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
BMJ : British Medical Journal, 333
F. Zijlstra, J. Hoorntje, M. Boer, S. Reiffers, K. Miedema, J. Ottervanger, A. Hof, H. Suryapranata (1999)
Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.
The New England journal of medicine, 341 19
Romagnoli (2012)
Radial vs. femoral randomized investigation in ST elevation acute coronary syndromes: The RIFLE STEACS study
J Am Coll Cardiol
W. Wijns, Philippe Kolh, Nicolas Danchin, Carlo Mario, Volkmar Falk, Thierry Folliguet, S. Garg, Kurt Huber, Stefan James, Juhani Knuuti, José López-Sendón, Jean Marco, Lorenzo Menicanti, M. Ostojić, M. Piepoli, Charles Pirlet, J. Pomar, Nicolaus Reifart, F. Ribichini, M. Schalij, Paul Sergeant, P. Serruys, S. Silber, M. Uva, D. Taggart (2010)
Guidelines on myocardial revascularization.
European heart journal, 31 20
A. Bavry, D. Kumbhani, Deepak Bhatt (2008)
Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials.
European heart journal, 29 24
A. Schömig, J. Mehilli, D. Antoniucci, G. Ndrepepa, Christina Markwardt, F. Pede, S. Nekolla, K. Schlotterbeck, H. Schühlen, J. Pache, M. Seyfarth, S. Martinoff, W. Benzer, C. Schmitt, J. Dirschinger, M. Schwaiger, A. Kastrati (2005)
Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial
JAMA, 293
Rodrigo Estévez-Loureiro, Ramón Calviño-Santos, J. Vázquez, Eduardo Barge-Caballero, J. Salgado-Fernández, Miriam Piñeiro, Miguel Freire-Tellado, Jacobo Varela-Portas, L. Martínez, Sandra Gómez, J. Rodríguez, N. Vázquez, Alfonso Castro-Beiras (2009)
Seguridad y viabilidad del retorno precoz de pacientes transferidos para angioplastia primaria a sus centros de origen
Revista Espanola De Cardiologia, 62
K. Huber, R. Caterina, S. Kristensen, F. Verheugt, G. Montalescot, L. Maestro, F. Werf (2005)
Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction.
European heart journal, 26 19
M. Hansen, R. Sørensen, M. Clausen, Marie Fog-Petersen, J. Raunsø, N. Gadsbøll, G. Gislason, F. Folke, S. Andersen, T. Schramm, S. Abildstrom, H. Poulsen, L. Køber, C. Torp-Pedersen (2010)
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation.
Archives of internal medicine, 170 16
R. Mehta, Aijing Starr, R. Lopes, J. Hochman, P. Widimsky, K. Pieper, P. Armstrong, C. Granger (2009)
Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.
JAMA, 301 17
S. Thackray, Joanne Easthaugh, N. Freemantle, J. Cleland (2002)
The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure—a meta‐regression analysis
European Journal of Heart Failure, 4
Stephen Bernard, T. Gray, Michael Buist, B. Jones, W. Silvester, G. Gutteridge, Karen Smith (2002)
Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.
The New England journal of medicine, 346 8
J. Cheng, C. Uil, S. Hoeks, M. Ent, L. Jewbali, R. Domburg, P. Serruys (2009)
Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
European heart journal, 30 17
Objectives Background Methods Results Conclusions
Jane Thomas, S. Paranjothy, D. James (2004)
National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section
BMJ : British Medical Journal, 328
P. Sorajja, B. Gersh, C. Costantini, M. McLaughlin, P. Zimetbaum, D. Cox, Eulogio García, J. Tcheng, R. Mehran, A. Lansky, D. Kandzari, C. Grines, G. Stone (2005)
Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction.
European heart journal, 26 7
A. Nordmann, P. Hengstler, T. Harr, James Young, H. Bucher (2004)
Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
The American journal of medicine, 116 4
J. Oldgren, L. Wallentin, Rizwan Afzal, J. Bassand, A. Budaj, S. Chrolavicius, K. Fox, C. Granger, S. Mehta, P. Pais, R. Peters, D. Xavier, Jun Zhu, S. Yusuf (2008)
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment.
European heart journal, 29 3
T. Jernberg, P. Johanson, C. Held, B. Svennblad, J. Lindbäck, L. Wallentin (2011)
Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction.
JAMA, 305 16
C. Thomson, N. Rigotti (2003)
Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease.
Progress in cardiovascular diseases, 45 6
L. Hine, N. Laird, P. Hewitt, T. Chalmers (1989)
Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction.
Archives of internal medicine, 149 12
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction (1993)
The GUSTO investigators
N Engl J Med, 329
P. Widimsky, D. Holmes (2010)
How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?
European Heart Journal, 32
R. Piccolo, S. Cassese, G. Galasso, R. Rosa, C. D'Anna, F. Piscione (2011)
Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials.
Atherosclerosis, 217 1
Dickstein (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur Heart J, 29
R. Taylor, Allan Brown, S. Ebrahim, J. Jolliffe, H. Noorani, K. Rees, B. Skidmore, J. Stone, D. Thompson, N. Oldridge (2004)
Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials.
The American journal of medicine, 116 10
W. Cantor, D. Fitchett, B. Borgundvaag, J. Ducas, M. Heffernan, E. Cohen, L. Morrison, A. Langer, V. Džavík, S. Mehta, C. Lazzam, Brian Schwartz, A. Casanova, S. Goodman (2009)
Routine early angioplasty after fibrinolysis for acute myocardial infarction.
The New England journal of medicine, 360 26
M. Costanzo, M. Guglin, M. Saltzberg, M. Jessup, B. Bart, J. Teerlink, B. Jaski, J. Fang, E. Feller, G. Haas, A. Anderson, M. Schollmeyer, P. Sobotka (2007)
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
Journal of the American College of Cardiology, 49 6
E. Bonnefoy, F. Lapostolle, A. Leizorovicz, G. Steg, E. Mcfadden, P. Dubien, S. Cattan, Eric Boullenger, J. Machecourt, Jean-Michel Lacroute, J. Cassagnes, François Dissait, P. Touboul (2002)
Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study
The Lancet, 360
Wiviott (2008)
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38
Circulation, 118
Seung‐Jung Park, Duk‐Woo Park, Young-Hak Kim, Soo-Jin Kang, Seung‐Whan Lee, Cheol-Whan Lee, K. Han, Seong-Wook Park, S. Yun, Sang‐Gon Lee, S. Rha, I. Seong, M. Jeong, S. Hur, N. Lee, Junghan Yoon, Joo Yang, Bong-Ki Lee, Y. Choi, W. Chung, D. Lim, S. Cheong, K. Kim, J. Chae, D. Nah, D. Jeon, K. Seung, Jae-Sik Jang, H. Park, Keun Lee (2010)
Duration of dual antiplatelet therapy after implantation of drug-eluting stents.
The New England journal of medicine, 362 15
J. Hochman, G. Lamas, C. Buller, V. Džavík, H. Reynolds, S. Abramsky, S. Forman, W. Rużyłło, A. Maggioni, H. White, Z. Sadowski, A. Carvalho, J. Rankin, J. Renkin, P. Steg, A. Mascette, G. Sopko, M. Pfisterer, J. Leor, V. Fridrich, D. Mark, G. Knatterud (2006)
Coronary intervention for persistent occlusion after myocardial infarction.
The New England journal of medicine, 355 23
Deepak Bhatt, B. Cryer, C. Contant, Marc Cohen, Á. Lanas, T. Schnitzer, T. Shook, P. Lapuerta, M. Goldsmith, L. Laine, B. Scirica, S. Murphy, C. Cannon (2010)
Clopidogrel with or without omeprazole in coronary artery disease.
The New England journal of medicine, 363 20
G. Montalescot, U. Zeymer, J. Silvain, B. Boulanger, Marc Cohen, P. Goldstein, P. Ecollan, X. Combes, K. Huber, C. Pollack, Jean-François Bénezet, O. Stibbe, E. Filippi, E. Teiger, G. Cayla, S. Elhadad, F. Adnet, T. Chouihed, S. Gallula, A. Greffet, M. Aout, J. Collet, E. Vicaut (2011)
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial
The Lancet, 378
T. Henry, S. Sharkey, M. Burke, Ivan Chavez, K. Graham, C. Henry, D. Lips, J. Madison, Katie Menssen, M. Mooney, M. Newell, W. Pedersen, A. Poulose, J. Traverse, Barbara Unger, Yale Wang, D. Larson (2007)
A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
Circulation, 116
K. Szummer, P. Lundman, S. Jacobson, S. Schön, J. Lindbäck, U. Stenestrand, L. Wallentin, T. Jernberg (2010)
Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register
Journal of Internal Medicine, 268
C. Baigent, A. Keech, P. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, R. Simes (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
The Lancet, 366
Anne Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino, K. Ferdinand, Malcolm Taylor, K. Adams, M. Sabolinski, M. Worcel, J. Cohn (2004)
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
The New England journal of medicine, 351 20
K. Fox, P. Steg, K. Eagle, S. Goodman, F. Anderson, C. Granger, M. Flather, A. Budaj, Ann Quill, J. Gore (2007)
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006.
JAMA, 297 17
A. Krishnaswamy, A. Lincoff, V. Menon (2009)
Magnitude and consequences of missing the acute infarct-related circumflex artery.
American heart journal, 158 5
M. Shah, V. Hasselblad, L. Stevenson, Cynthia Binanay, C. O'connor, G. Sopko, R. Califf (2005)
Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials.
JAMA, 294 13
S. Yusuf, F. Zhao, S. Mehta, S. Chrolavicius, G. Tognoni, K. Fox, Clopidogrel Investigators (2001)
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
The New England journal of medicine, 345 7
H. Dargie (2001)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
The Lancet, 357
G. Luca, E. Navarese, P. Marino (2009)
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials
European Heart Journal, 30
Nie Fe (1990)
Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)
American Journal of Cardiology, 66
J. Ioannidis, D. Katritsis (2007)
Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients.
American heart journal, 154 6
N. Danchin, P. Coste, J. Ferrières, P. Steg, Y. Cottin, D. Blanchard, L. Belle, B. Ritz, G. Kirkorian, M. Angioi, P. Sans, B. Charbonnier, H. Eltchaninoff, P. Guéret, K. Khalifé, P. Asseman, J. Puel, P. Goldstein, J. Cambou, T. Simon (2008)
Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Acute Myocardial Infarction: Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI)
Circulation, 118
F. Fernández‐Avilés, J. Alonso, G. Peña, Jesús Blanco, J. Alonso-Briales, Juan López-Mesa, F. Fernández-Vázquez, J. Moreu, Rosa Hernández, A. Castro‐Beiras, R. Gabriel, C. Gibson, P. Sánchez (2007)
Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial.
European heart journal, 28 8
S. Yusuf, S. Mehta, S. Chrolavicius, Rizwan Afzal, J. Pogue, C. Granger, A. Budaj, R. Peters, J. Bassand, L. Wallentin, C. Joyner, K. Fox (2006)
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.
JAMA, 295 13
B. Levy, P. Pérez, J. Perny, C. Thivilier, A. Gérard (2011)
Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study*
Critical Care Medicine, 39
R. Welsh, Wei-Ching Chang, P. Goldstein, J. Adgey, C. Granger, F. Verheugt, L. Wallentin, F. Werf, P. Armstrong (2005)
Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial
Heart, 91
J. Piccini, P. Hranitzky, R. Kilaru, J. Rouleau, H. White, P. Aylward, F. Werf, S. Solomon, R. Califf, E. Velazquez (2008)
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
The American journal of cardiology, 102 11
A. Rubboli, J. Halperin, K. Airaksinen, M. Buerke, É. Eeckhout, S. Freedman, A. Gershlick, A. Schlitt, Hung Tse, F. Verheugt, G. Lip (2008)
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation
Annals of Medicine, 40
A. Catapano, Željko Reiner, G. Backer, I. Graham, M. Taskinen, O. Wiklund, S. Agewall, E. Alegrı́a, M. Chapman, P. Durrington, S. Erdine, J. Halcox, Richard Hobbs, J. Kjekshus, P. Filardi, G. Riccardi, R. Storey, D. Wood, P. Kolh (2011)
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
European heart journal, 32 14
D. Morrow, E. Antman, A. Charlesworth, Richard Cairns, S. Murphy, J. Lemos, R. Giugliano, C. Mccabe, E. Braunwald (2000)
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy
Circulation: Journal of the American Heart Association, 102
J. Segal, R. McNamara, Marlene Miller, N. Kim, S. Goodman, N. Powe, K. Robinson, David Yu, E. Bass (2000)
The evidence regarding the drugs used for ventricular rate control.
The Journal of family practice, 49 1
I. Rokos, W. French, W. Koenig, S. Stratton, Beverly Nighswonger, B. Strunk, J. Jewell, E. Mahmud, J. Dunford, J. Hokanson, Stephen Smith, K. Baran, R. Swor, A. Berman, B. Wilson, Akinyele Aluko, B. Gross, P. Rostykus, Angelo Salvucci, V. Dev, Bryan McNally, S. Manoukian, S. King (2009)
Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks: impact on Door-to-Balloon times across 10 independent regions.
JACC. Cardiovascular interventions, 2 4
C. Mario, D. Dudek, F. Piscione, Waldemar Mielecki, S. Savonitto, E. Murena, K. Dimopoulos, A. Manari, A. Gaspardone, A. Ochała, K. Żmudka, L. Bolognese, P. Steg, M. Flather (2008)
Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial
The Lancet, 371
J. Silvain, F. Beygui, O. Barthelemy, C. Pollack, Marc Cohen, U. Zeymer, K. Huber, P. Goldstein, G. Cayla, J. Collet, E. Vicaut, G. Montalescot (2012)
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
The BMJ, 344
M. Hazinski, J. Nolan, J. Billi, B. Böttiger, L. Bossaert, A. Caen, C. Deakin, S. Drajer, B. Eigel, R. Hickey, I. Jacobs, M. Kleinman, W. Kloeck, R. Koster, S. Lim, M. Mancini, W. Montgomery, P. Morley, L. Morrison, V. Nadkarni, R. O’Connor, K. Okada, J. Perlman, M. Sayre, M. Shuster, J. Soar, K. Sunde, A. Travers, J. Wyllie, D. Zideman (2010)
Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
Circulation, 122 16 Suppl 2
M. Toma, C. Buller, C. Westerhout, Yuling Fu, W. O’Neill, D. Holmes, C. Hamm, C. Granger, P. Armstrong (2010)
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
European heart journal, 31 14
A. Schömig, Franz‐Josef Neumann, A. Kastrati, H. Schühlen, R. Blasini, M. Hadamitzky, H. Walter, E. Zitzmann-Roth, G. Richardt, E. Alt, C. Schmitt, K. Ulm (1996)
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
The New England journal of medicine, 334 17
A. Senthinathan, Victoria Kelly, M. Dzingina, D. Jones, M. Baker, D. Longson (2011)
Hyperglycaemia in acute coronary syndromes: summary of NICE guidance
BMJ : British Medical Journal, 343
B. Pitt, F. Zannad, W. Remme, R. Cody, A. Castaigne, Alfonso Perez, J. Palensky, J. Wittes (2000)
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Survey of Anesthesiology, 44
K. Swedberg, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. Smiseth, A. Gavazzi, A. Haverich, A. Hoes, T. Jaarsma, J. Korewicki, Samuel Lévy, C. Linde, J. López-Sendón, M. Nieminen, L. Pierard, W. Remme (2005)
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.
European heart journal, 26 11
E. Boersma (2006)
Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.
European heart journal, 27 7
G. Ndrepepa, A. Kastrati, J. Mehilli, D. Antoniucci, A. Schömig (2009)
Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms.
JAMA, 301 5
M. Bartnik, K. Malmberg, A. Norhammar, A. Tenerz, J. Öhrvik, L. Rydén (2004)
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.
European heart journal, 25 22
L. Wallentin, R. Becker, A. Budaj, C. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K. Mahaffey, B. Scirica, A. Skene, P. Steg, R. Storey, R. Harrington, A. Freij, M. Thorsén (2009)
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
The New England journal of medicine, 361 11
A. Yan, R. Yan, B. Kennelly, F. Anderson, A. Budaj, J. López-Sendón, D. Brieger, Jeanna Allegrone, G. Steg, S. Goodman (2007)
Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromes.
American heart journal, 154 1
Z. Hou, Ming-Shan Chang, C.‐Y. Chen, M.-S. Tu, S.-L. Lin, H. Chiang, R. Woosley (1995)
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study.
European heart journal, 16 4
C. Taylor, N. Houston-Miller, J. Killen, R. Debusk (1990)
Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention.
Annals of internal medicine, 113 2
R. Jeger, A. Lowe, C. Buller, M. Pfisterer, V. Džavík, J. Webb, J. Hochman, U. Jorde (2007)
Hemodynamic parameters are prognostically important in cardiogenic shock but similar following early revascularization or initial medical stabilization: a report from the SHOCK Trial.
Chest, 132 6
S. Steinhubl, Peter Berger, J. III, Edward Fry, A. Delago, C. Wilmer, E. Topol (2002)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
JAMA, 288 19
X. Freixa, N. Bellera, J. Ortiz-Perez, M. Jimenez, C. Paré, X. Bosch, T. Caralt, A. Betriu, M. Masotti (2012)
Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention.
European heart journal, 33 1
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group
Lancet, 343
T. Simon, P. Steg, Martine Gilard, Didier Blanchard, Laurent Bonello, Michel Hanssen, Hervé Lardoux, P. Coste, Thierry Lefèvre, E. Drouet, G. Mulak, V. Bataille, Jean Ferrières, Céline Verstuyft, N. Danchin (2011)
Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction: Results From the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Registry
Circulation, 123
S. Savonitto, M. D’Urbano, M. Caracciolo, F. Barlocco, G. Mariani, M. Nichelatti, S. Klugmann, S. Servi (2010)
Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel.
British journal of anaesthesia, 104 3
Michael O'Doherty, D. Tayler, Eileen Quinn, R. Vincent, Douglas Chamberlain (1983)
Five hundred patients with myocardial infarction monitored within one hour of symptoms.
British Medical Journal (Clinical research ed.), 286
E. Antman, H. Louwerenburg, H. Baars, J. Wesdorp, B. Hamer, J. Bassand, F. Bigonzi, G. Pisapia, C. Gibson, H. Heidbuchel, E. Braunwald, F. Werf (2002)
Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial
Circulation: Journal of the American Heart Association, 105
J. Oldgren, A. Budaj, C. Granger, Y. Khder, Juliet Roberts, A. Siegbahn, J. Tijssen, F. Werf, L. Wallentin (2011)
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial.
European heart journal, 32 22
D. Faxon, J. Eikelboom, P. Berger, D. Holmes, Deepak Bhatt, D. Moliterno, R. Becker, D. Angiolillo (2011)
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Coronary Stenting: A North American Perspective: Executive Summary
Circulation: Cardiovascular Interventions, 4
D. Kromhout, E. Giltay, J. Geleijnse (2010)
n-3 fatty acids and cardiovascular events after myocardial infarction.
The New England journal of medicine, 363 21
P. Garot, T. Lefévre, H. Eltchaninoff, M. Morice, F. Tamion, B. Abry, P. Lesault, J. Tarnec, C. Pouges, A. Margenet, M. Monchi, I. Laurent, P. Dumas, J. Garot, Y. Louvard (2007)
Six-Month Outcome of Emergency Percutaneous Coronary Intervention in Resuscitated Patients After Cardiac Arrest Complicating ST-Elevation Myocardial Infarction
Circulation, 115
D. McManus, J. Gore, J. Yarzebski, F. Spencer, D. Lessard, R. Goldberg (2011)
Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI.
The American journal of medicine, 124 1
M. Fokkema, P. Vlaar, T. Svilaas, M. Vogelzang, D. Amo, G. Diercks, A. Suurmeijer, F. Zijlstra (2009)
Incidence and clinical consequences of distal embolization on the coronary angiogram after primary percutaneous coronary intervention for ST-elevation myocardial infarction
Journal of the American College of Cardiology, 53

Publisher: Oxford University Press
Copyright: © The European Society of Cardiology 2012. All rights reserved. For permissions please email: [email protected]
Subject: ESC GUIDELINES
ISSN: 0195-668X
eISSN: 1522-9645
DOI: 10.1093/eurheartj/ehs215
pmid: 22922416
Publisher site: See Article on Publisher Site

Abstract

ESC GUIDELINES European Heart Journal (2012) 33, 2569–2619 doi:10.1093/eurheartj/ehs215 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) Authors/Task Force Members: Ph. Gabriel Steg (Chairperson) (France)*, Stefan K. James (Chairperson) (Sweden) , Dan Atar (Norway), Luigi P. Badano (Italy), Carina Blomstrom-Lundqvist (Sweden), Michael A. Borger (Germany), Carlo Di Mario (United Kingdom), Kenneth Dickstein (Norway), Gregory Ducrocq (France), Francisco Fernandez-Aviles (Spain), Anthony H. Gershlick (United Kingdom), Pantaleo Giannuzzi (Italy), Sigrun Halvorsen (Norway), Kurt Huber (Austria), Peter Juni (Switzerland), Adnan Kastrati (Germany), Juhani Knuuti (Finland), Mattie J. Lenzen (Netherlands), Kenneth W. Mahaffey (USA), Marco Valgimigli (Italy), Arnoud van ’t Hof (Netherlands), Petr Widimsky (Czech Republic), Doron Zahger (Israel) ESC Committee for Practice Guidelines (CPG): Jeroen J. Bax (Chairman) (Netherlands), Helmut Baumgartner (Germany), Claudio Ceconi (Italy), Veronica Dean (France), Christi Deaton (UK), Robert Fagard (Belgium), Christian Funck-Brentano (France), David Hasdai (Israel), Arno Hoes (Netherlands), Paulus Kirchhof (Germany UK), Juhani Knuuti (Finland), Philippe Kolh (Belgium), Theresa McDonagh (UK), Cyril Moulin (France), Bogdan A. Popescu (Romania), Zeljko Reiner (Croatia), Udo Sechtem (Germany), Per Anton Sirnes (Norway), Michal Tendera (Poland),

Journal

European Heart Journal – Oxford University Press

Published: Oct 24, 2012

Keywords: Guidelines Acute myocardial infarction ST-segment elevation Acute coronary syndromes Ischaemic heart disease Reperfusion therapy Primary percutaneous coronary intervention Antithrombotic therapy Secondary prevention

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

References (380)

Abstract

Journal

Recommended Articles

There are no references for this article.

Our policy towards the use of cookies